User login
Where have all the young men gone? Not to obstetrics and gynecology
Where have all the young men gone?
Long time passing
Where have all the young men gone?
Long time ago
—Pete Seeger (1961)
The first decade of the 21st century brought amazing changes in medicine. New technologies were introduced at a vigorous rate—and were often accepted with little analysis of their benefits and at higher cost than older technology.
The physician workforce also was transformed. Baby Boomers continued to retire, and we saw an influx of practitioners from Generations X and Y.1,2,3
One additional change appears to be unique to the specialty of obstetrics and gynecology: a complete gender reversal among practitioners. Before 1980, female ObGyns were uncommon—and that was a problem. Today, 80% to 90% of all ObGyn residents are female!4 That’s despite the fact that the genders are roughly equal in number among medical students. The question that folk singer and songwriter Pete Seeger asked 50 years ago is highly relevant today: Where have all the young men gone?
The leaders of our profession clearly need to decide whether this gender disparity is healthy for the specialty. If they decide that it is not, we need to formulate a set of actions to address it.
A perfect 10
The breadth of this gender gap came home to me recently as I read the Sunday newspaper. I spied a half-page advertisement for an ObGyn group practice with the following headline: “A perfect 10” (a possible reference to the 1979 motion picture “10,” starring Bo Derek). The advertisement depicted nine young women—all of whom appeared to be younger than 40 years—and one man, considerably older, who represented the “gray-hair” of the group. I would venture to predict that, when the gray-hair retires, he will be replaced by a practitioner of the opposite gender.
What message does such an advertisement send to male medical students who may be considering a career in ObGyn? I believe that many male medical students worry whether they will have a place in the profession once they finish their training.
A recent American Medical Association member communication (September 20, 2010) discussed a report that men are entering the nursing profession at the highest level ever recorded. One has to wonder what social and economic issues are fomenting changes such as the surge of male nurses and the predominance of female ObGyns? How will medical care be affected (if at all) by these role reversals? Has the medical profession truly become blind to gender? It certainly does not appear to be that way in the fields of orthopedics and neurosurgery, where men predominate, or in obstetrics and gynecology, where women do.
No diatribe
Although this commentary may be viewed by many readers as nothing more than a sexist diatribe by a resentful Baby Boomer physician, I can assure you, that is not the case. Throughout my career, I have emphasized our need for the best and brightest physicians—regardless of gender—in our profession. I have also written about the need to make lifestyle accommodations for Generation X and Y physicians—again, regardless of gender—so that they can be happy and successful practitioners.1,3
Why is the gender shift in obstetrics and gynecology worthy of our attention?
Because if it continues, there is the potential that many gifted and caring male physicians will bypass our specialty. Who knows if one of these male physicians would have been the discoverer of the cause of preeclampsia? Also, evidence suggests that female physicians work shorter work weeks than their male counterparts, take less call, and leave the practice of obstetrics earlier than males, even after accounting for generational differences.5,6 This means that the predicted physician shortage will become more severe if this trend continues.
One often-cited reason for the increasing numbers of women entering the ObGyn workforce is a desire to meet the needs of female patients. The evidence suggests that gender is rarely the sole criterion a patient uses when selecting an ObGyn. In fact, gender seems to be a minor consideration, compared with other physician attributes, such as respectfulness, attentiveness, and the ability to perform a painless pelvic examination.7
A few recommendations
Regardless of how the gender- disparity issue is resolved—or isn’t—a few steps can help to make obstetrics and gynecology better for everyone, including the patient:
- Limit the physician work week to 50 hours (soon the federal government will mandate this)
- Implement the laborist model for any obstetric service that delivers more than 1,000 babies per year
- Institute job sharing, with parttime professional liability policies or policy slotting made available
- Educate all practitioners about time and money management so that they can deal with family and personal issues and manage the large debt accumulated during medical education.
Will we ever return to gender parity in obstetrics and gynecology? Personally, I think not.
Nevertheless, I would hope that all of us are trying to create a profession that will be welcoming to all.
- What can be safer than having a baby in the USA?
(May 2010) - You may not have noticed, but your workload is lighter. So is your wallet.
(March 2010, Web exclusive) - Can a change in practice patterns reduce the number of OB malpractice claims?
(April 2009) - The unbearable unhappiness of the ObGyn: A crisis looms
(December 2008)
We want to hear from you! Tell us what you think.
1. Phelan ST. Generational issues in the Ob-Gyn workplace: “Marcus Welby, MD,” versus "Scrubs". Obstet Gynecol. 2010;116(6):568-569.
2. Weinstein L. The residency certificate: the right of passage. Obstet Gynecol. 2010;116(3):744-746.
3. Weinstein L, Wolfe HM. The downward spiral of physician satisfaction: an attempt to avert a crisis within the medical profession. Obstet Gynecol. 2007;109(5):1181-1183.
4. Association of American Medical Colleges AAMC Data Book: Medical Schools and Teaching Hospitals by the Numbers 2010. Washington, DC: AAMC; 2010.
5. Keeton K, Fenner DE, Johnson TR, Hayward RA. Predictors of physician career satisfaction, work-life balance, and burnout. Obstet Gynecol. 2007;109(4):949-955.
6. Landon BE, Reschovsky JD, Pham HH, Blumenthal D. Leaving medicine: the consequences of physician dissatisfaction. Med Care. 2006;44(3):234-242.
7. Johnson AM, Schnatz PF, Kelsey AM, Ohannessian CM. Do women prefer care from female or male obstetrician-gynecologists? A study of patient gender preference. J Am Osteopath Assoc. 2005;105(8):369-379.
Where have all the young men gone?
Long time passing
Where have all the young men gone?
Long time ago
—Pete Seeger (1961)
The first decade of the 21st century brought amazing changes in medicine. New technologies were introduced at a vigorous rate—and were often accepted with little analysis of their benefits and at higher cost than older technology.
The physician workforce also was transformed. Baby Boomers continued to retire, and we saw an influx of practitioners from Generations X and Y.1,2,3
One additional change appears to be unique to the specialty of obstetrics and gynecology: a complete gender reversal among practitioners. Before 1980, female ObGyns were uncommon—and that was a problem. Today, 80% to 90% of all ObGyn residents are female!4 That’s despite the fact that the genders are roughly equal in number among medical students. The question that folk singer and songwriter Pete Seeger asked 50 years ago is highly relevant today: Where have all the young men gone?
The leaders of our profession clearly need to decide whether this gender disparity is healthy for the specialty. If they decide that it is not, we need to formulate a set of actions to address it.
A perfect 10
The breadth of this gender gap came home to me recently as I read the Sunday newspaper. I spied a half-page advertisement for an ObGyn group practice with the following headline: “A perfect 10” (a possible reference to the 1979 motion picture “10,” starring Bo Derek). The advertisement depicted nine young women—all of whom appeared to be younger than 40 years—and one man, considerably older, who represented the “gray-hair” of the group. I would venture to predict that, when the gray-hair retires, he will be replaced by a practitioner of the opposite gender.
What message does such an advertisement send to male medical students who may be considering a career in ObGyn? I believe that many male medical students worry whether they will have a place in the profession once they finish their training.
A recent American Medical Association member communication (September 20, 2010) discussed a report that men are entering the nursing profession at the highest level ever recorded. One has to wonder what social and economic issues are fomenting changes such as the surge of male nurses and the predominance of female ObGyns? How will medical care be affected (if at all) by these role reversals? Has the medical profession truly become blind to gender? It certainly does not appear to be that way in the fields of orthopedics and neurosurgery, where men predominate, or in obstetrics and gynecology, where women do.
No diatribe
Although this commentary may be viewed by many readers as nothing more than a sexist diatribe by a resentful Baby Boomer physician, I can assure you, that is not the case. Throughout my career, I have emphasized our need for the best and brightest physicians—regardless of gender—in our profession. I have also written about the need to make lifestyle accommodations for Generation X and Y physicians—again, regardless of gender—so that they can be happy and successful practitioners.1,3
Why is the gender shift in obstetrics and gynecology worthy of our attention?
Because if it continues, there is the potential that many gifted and caring male physicians will bypass our specialty. Who knows if one of these male physicians would have been the discoverer of the cause of preeclampsia? Also, evidence suggests that female physicians work shorter work weeks than their male counterparts, take less call, and leave the practice of obstetrics earlier than males, even after accounting for generational differences.5,6 This means that the predicted physician shortage will become more severe if this trend continues.
One often-cited reason for the increasing numbers of women entering the ObGyn workforce is a desire to meet the needs of female patients. The evidence suggests that gender is rarely the sole criterion a patient uses when selecting an ObGyn. In fact, gender seems to be a minor consideration, compared with other physician attributes, such as respectfulness, attentiveness, and the ability to perform a painless pelvic examination.7
A few recommendations
Regardless of how the gender- disparity issue is resolved—or isn’t—a few steps can help to make obstetrics and gynecology better for everyone, including the patient:
- Limit the physician work week to 50 hours (soon the federal government will mandate this)
- Implement the laborist model for any obstetric service that delivers more than 1,000 babies per year
- Institute job sharing, with parttime professional liability policies or policy slotting made available
- Educate all practitioners about time and money management so that they can deal with family and personal issues and manage the large debt accumulated during medical education.
Will we ever return to gender parity in obstetrics and gynecology? Personally, I think not.
Nevertheless, I would hope that all of us are trying to create a profession that will be welcoming to all.
- What can be safer than having a baby in the USA?
(May 2010) - You may not have noticed, but your workload is lighter. So is your wallet.
(March 2010, Web exclusive) - Can a change in practice patterns reduce the number of OB malpractice claims?
(April 2009) - The unbearable unhappiness of the ObGyn: A crisis looms
(December 2008)
We want to hear from you! Tell us what you think.
Where have all the young men gone?
Long time passing
Where have all the young men gone?
Long time ago
—Pete Seeger (1961)
The first decade of the 21st century brought amazing changes in medicine. New technologies were introduced at a vigorous rate—and were often accepted with little analysis of their benefits and at higher cost than older technology.
The physician workforce also was transformed. Baby Boomers continued to retire, and we saw an influx of practitioners from Generations X and Y.1,2,3
One additional change appears to be unique to the specialty of obstetrics and gynecology: a complete gender reversal among practitioners. Before 1980, female ObGyns were uncommon—and that was a problem. Today, 80% to 90% of all ObGyn residents are female!4 That’s despite the fact that the genders are roughly equal in number among medical students. The question that folk singer and songwriter Pete Seeger asked 50 years ago is highly relevant today: Where have all the young men gone?
The leaders of our profession clearly need to decide whether this gender disparity is healthy for the specialty. If they decide that it is not, we need to formulate a set of actions to address it.
A perfect 10
The breadth of this gender gap came home to me recently as I read the Sunday newspaper. I spied a half-page advertisement for an ObGyn group practice with the following headline: “A perfect 10” (a possible reference to the 1979 motion picture “10,” starring Bo Derek). The advertisement depicted nine young women—all of whom appeared to be younger than 40 years—and one man, considerably older, who represented the “gray-hair” of the group. I would venture to predict that, when the gray-hair retires, he will be replaced by a practitioner of the opposite gender.
What message does such an advertisement send to male medical students who may be considering a career in ObGyn? I believe that many male medical students worry whether they will have a place in the profession once they finish their training.
A recent American Medical Association member communication (September 20, 2010) discussed a report that men are entering the nursing profession at the highest level ever recorded. One has to wonder what social and economic issues are fomenting changes such as the surge of male nurses and the predominance of female ObGyns? How will medical care be affected (if at all) by these role reversals? Has the medical profession truly become blind to gender? It certainly does not appear to be that way in the fields of orthopedics and neurosurgery, where men predominate, or in obstetrics and gynecology, where women do.
No diatribe
Although this commentary may be viewed by many readers as nothing more than a sexist diatribe by a resentful Baby Boomer physician, I can assure you, that is not the case. Throughout my career, I have emphasized our need for the best and brightest physicians—regardless of gender—in our profession. I have also written about the need to make lifestyle accommodations for Generation X and Y physicians—again, regardless of gender—so that they can be happy and successful practitioners.1,3
Why is the gender shift in obstetrics and gynecology worthy of our attention?
Because if it continues, there is the potential that many gifted and caring male physicians will bypass our specialty. Who knows if one of these male physicians would have been the discoverer of the cause of preeclampsia? Also, evidence suggests that female physicians work shorter work weeks than their male counterparts, take less call, and leave the practice of obstetrics earlier than males, even after accounting for generational differences.5,6 This means that the predicted physician shortage will become more severe if this trend continues.
One often-cited reason for the increasing numbers of women entering the ObGyn workforce is a desire to meet the needs of female patients. The evidence suggests that gender is rarely the sole criterion a patient uses when selecting an ObGyn. In fact, gender seems to be a minor consideration, compared with other physician attributes, such as respectfulness, attentiveness, and the ability to perform a painless pelvic examination.7
A few recommendations
Regardless of how the gender- disparity issue is resolved—or isn’t—a few steps can help to make obstetrics and gynecology better for everyone, including the patient:
- Limit the physician work week to 50 hours (soon the federal government will mandate this)
- Implement the laborist model for any obstetric service that delivers more than 1,000 babies per year
- Institute job sharing, with parttime professional liability policies or policy slotting made available
- Educate all practitioners about time and money management so that they can deal with family and personal issues and manage the large debt accumulated during medical education.
Will we ever return to gender parity in obstetrics and gynecology? Personally, I think not.
Nevertheless, I would hope that all of us are trying to create a profession that will be welcoming to all.
- What can be safer than having a baby in the USA?
(May 2010) - You may not have noticed, but your workload is lighter. So is your wallet.
(March 2010, Web exclusive) - Can a change in practice patterns reduce the number of OB malpractice claims?
(April 2009) - The unbearable unhappiness of the ObGyn: A crisis looms
(December 2008)
We want to hear from you! Tell us what you think.
1. Phelan ST. Generational issues in the Ob-Gyn workplace: “Marcus Welby, MD,” versus "Scrubs". Obstet Gynecol. 2010;116(6):568-569.
2. Weinstein L. The residency certificate: the right of passage. Obstet Gynecol. 2010;116(3):744-746.
3. Weinstein L, Wolfe HM. The downward spiral of physician satisfaction: an attempt to avert a crisis within the medical profession. Obstet Gynecol. 2007;109(5):1181-1183.
4. Association of American Medical Colleges AAMC Data Book: Medical Schools and Teaching Hospitals by the Numbers 2010. Washington, DC: AAMC; 2010.
5. Keeton K, Fenner DE, Johnson TR, Hayward RA. Predictors of physician career satisfaction, work-life balance, and burnout. Obstet Gynecol. 2007;109(4):949-955.
6. Landon BE, Reschovsky JD, Pham HH, Blumenthal D. Leaving medicine: the consequences of physician dissatisfaction. Med Care. 2006;44(3):234-242.
7. Johnson AM, Schnatz PF, Kelsey AM, Ohannessian CM. Do women prefer care from female or male obstetrician-gynecologists? A study of patient gender preference. J Am Osteopath Assoc. 2005;105(8):369-379.
1. Phelan ST. Generational issues in the Ob-Gyn workplace: “Marcus Welby, MD,” versus "Scrubs". Obstet Gynecol. 2010;116(6):568-569.
2. Weinstein L. The residency certificate: the right of passage. Obstet Gynecol. 2010;116(3):744-746.
3. Weinstein L, Wolfe HM. The downward spiral of physician satisfaction: an attempt to avert a crisis within the medical profession. Obstet Gynecol. 2007;109(5):1181-1183.
4. Association of American Medical Colleges AAMC Data Book: Medical Schools and Teaching Hospitals by the Numbers 2010. Washington, DC: AAMC; 2010.
5. Keeton K, Fenner DE, Johnson TR, Hayward RA. Predictors of physician career satisfaction, work-life balance, and burnout. Obstet Gynecol. 2007;109(4):949-955.
6. Landon BE, Reschovsky JD, Pham HH, Blumenthal D. Leaving medicine: the consequences of physician dissatisfaction. Med Care. 2006;44(3):234-242.
7. Johnson AM, Schnatz PF, Kelsey AM, Ohannessian CM. Do women prefer care from female or male obstetrician-gynecologists? A study of patient gender preference. J Am Osteopath Assoc. 2005;105(8):369-379.
Can nonhormonal treatments relieve hot flushes in breast Ca survivors?
A frequent challenge facing clinicians who manage breast cancer survivors is identifying treatment options to attenuate hot flushes and night sweats without resorting to estrogen, which is contraindicated because it can induce cancer growth.
Variables associated with a high prevalence of hot flushes in this population:
- age at diagnosis (>50 years)
- abrupt discontinuation of estrogen therapy at diagnosis
- induction of premature menopause by therapy (i.e., chemotherapy and surgical or medical ovarian ablation)
- induction of estrogen deficiency symptoms by chemotherapy (e.g., tamoxifen or an aromatase inhibitor).
There are no FDA-approved nonhormonal pharmaceutical options to alleviate bothersome hot flushes that accompany breast cancer treatment and the menopausal transition, whether spontaneous or induced. Moreover, meaningful guidance from published trials is limited by the small number of enrolled subjects and short duration of study (i.e., ≤12 weeks).
How hot flushes happen
According to Freedman, body temperature is regulated over a range called the thermo-neutral zone.1,2 Reduced or fluctuating ovarian hormones are believed to narrow the thermoregulatory zone such that variations in core body temperature trigger heat loss mechanisms. A narrowed thermoregulatory zone has been associated with increased norepinephrine.
Clonidine, an α-2 adrenergic agonist, decreases norepinephrine and has been found to reduce hot flushes. Other nonhormonal agents that have been found to be at least partially effective in reducing hot flushes include SSRI and SNRI antidepressants, which enhance central serotonin and norepinephrine activity. Gabapentin has also proved to be effective.
Potential adverse events or negative side effects, such as insomnia, weight gain, drowsiness, and sedation, need to be taken into account when evaluating the benefits of pharmaceutical options.
There are no FDA-approved nonhormonal therapies for hot-flush reduction in breast cancer survivors.
Potentially effective drug therapies include clonidine, SSRIs, SNRIs, and gabapentin. Benefits need to be weighed carefully against side effects, because the reduction in absolute hot flushes is only mild to moderate.
Nonpharmaceutical therapies that are not beneficial include homeopathy, magnet therapy, and acupuncture. However, more recent RCT data suggest that, in breast cancer patients, traditional acupuncture (and, in some studies, sham acupuncture) may, in fact, significantly reduce frequency of hot flushes, with a prolonged reduction at 3 to 6 months.3,4 Relaxation therapy has a modest benefit.
When a patient reports bothersome hot flushes, I recommend that she avoid overheating, use cooling techniques, and try relaxation therapy or acupuncture.
For medical therapy, I usually recommend venlafaxine or gabapentin, both of which have an effect on hot flushes within 2 weeks and both of which are associated with side effects. I start with 37.5 mg of venlafaxine, increasing to 75 mg after 2 weeks, if needed. If using gabapentin, I start with 300 mg, increasing to 600 mg at night and adding 300 mg in the morning or afternoon, if needed, aiming for 900 to 1,800 mg per day.
For vaginal dryness, I recommend vaginal moisturizers (used twice weekly) and lubricants (as needed) for sexual activity. The use of vaginal dilators or topical estrogen therapy is individualized.—JOANN V. PINKERTON, MD
We want to hear from you! Tell us what you think.
1. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol. 1999;181(1):66-70.
2. Freedman RR. Core body temperature variation in symptomatic and asymptomatic postmenopausal women: brief report. Menopause. 2002;9(6):399-401.
3. Hervik J, Mialand O. Acupuncture for the treatment of hot flashes in breast cancer patients: a randomized, controlled trial. Breast Cancer Res Treat. 2009;116(2):311-316.
4. de Valois BA, Young TE, Robinson N, McCourt C, Maher EJ. Using traditional acupuncture for breast cancer-related hot flashes and night sweats. J Altern Complement Med. 2010;16(10):1047-1057.
A frequent challenge facing clinicians who manage breast cancer survivors is identifying treatment options to attenuate hot flushes and night sweats without resorting to estrogen, which is contraindicated because it can induce cancer growth.
Variables associated with a high prevalence of hot flushes in this population:
- age at diagnosis (>50 years)
- abrupt discontinuation of estrogen therapy at diagnosis
- induction of premature menopause by therapy (i.e., chemotherapy and surgical or medical ovarian ablation)
- induction of estrogen deficiency symptoms by chemotherapy (e.g., tamoxifen or an aromatase inhibitor).
There are no FDA-approved nonhormonal pharmaceutical options to alleviate bothersome hot flushes that accompany breast cancer treatment and the menopausal transition, whether spontaneous or induced. Moreover, meaningful guidance from published trials is limited by the small number of enrolled subjects and short duration of study (i.e., ≤12 weeks).
How hot flushes happen
According to Freedman, body temperature is regulated over a range called the thermo-neutral zone.1,2 Reduced or fluctuating ovarian hormones are believed to narrow the thermoregulatory zone such that variations in core body temperature trigger heat loss mechanisms. A narrowed thermoregulatory zone has been associated with increased norepinephrine.
Clonidine, an α-2 adrenergic agonist, decreases norepinephrine and has been found to reduce hot flushes. Other nonhormonal agents that have been found to be at least partially effective in reducing hot flushes include SSRI and SNRI antidepressants, which enhance central serotonin and norepinephrine activity. Gabapentin has also proved to be effective.
Potential adverse events or negative side effects, such as insomnia, weight gain, drowsiness, and sedation, need to be taken into account when evaluating the benefits of pharmaceutical options.
There are no FDA-approved nonhormonal therapies for hot-flush reduction in breast cancer survivors.
Potentially effective drug therapies include clonidine, SSRIs, SNRIs, and gabapentin. Benefits need to be weighed carefully against side effects, because the reduction in absolute hot flushes is only mild to moderate.
Nonpharmaceutical therapies that are not beneficial include homeopathy, magnet therapy, and acupuncture. However, more recent RCT data suggest that, in breast cancer patients, traditional acupuncture (and, in some studies, sham acupuncture) may, in fact, significantly reduce frequency of hot flushes, with a prolonged reduction at 3 to 6 months.3,4 Relaxation therapy has a modest benefit.
When a patient reports bothersome hot flushes, I recommend that she avoid overheating, use cooling techniques, and try relaxation therapy or acupuncture.
For medical therapy, I usually recommend venlafaxine or gabapentin, both of which have an effect on hot flushes within 2 weeks and both of which are associated with side effects. I start with 37.5 mg of venlafaxine, increasing to 75 mg after 2 weeks, if needed. If using gabapentin, I start with 300 mg, increasing to 600 mg at night and adding 300 mg in the morning or afternoon, if needed, aiming for 900 to 1,800 mg per day.
For vaginal dryness, I recommend vaginal moisturizers (used twice weekly) and lubricants (as needed) for sexual activity. The use of vaginal dilators or topical estrogen therapy is individualized.—JOANN V. PINKERTON, MD
We want to hear from you! Tell us what you think.
A frequent challenge facing clinicians who manage breast cancer survivors is identifying treatment options to attenuate hot flushes and night sweats without resorting to estrogen, which is contraindicated because it can induce cancer growth.
Variables associated with a high prevalence of hot flushes in this population:
- age at diagnosis (>50 years)
- abrupt discontinuation of estrogen therapy at diagnosis
- induction of premature menopause by therapy (i.e., chemotherapy and surgical or medical ovarian ablation)
- induction of estrogen deficiency symptoms by chemotherapy (e.g., tamoxifen or an aromatase inhibitor).
There are no FDA-approved nonhormonal pharmaceutical options to alleviate bothersome hot flushes that accompany breast cancer treatment and the menopausal transition, whether spontaneous or induced. Moreover, meaningful guidance from published trials is limited by the small number of enrolled subjects and short duration of study (i.e., ≤12 weeks).
How hot flushes happen
According to Freedman, body temperature is regulated over a range called the thermo-neutral zone.1,2 Reduced or fluctuating ovarian hormones are believed to narrow the thermoregulatory zone such that variations in core body temperature trigger heat loss mechanisms. A narrowed thermoregulatory zone has been associated with increased norepinephrine.
Clonidine, an α-2 adrenergic agonist, decreases norepinephrine and has been found to reduce hot flushes. Other nonhormonal agents that have been found to be at least partially effective in reducing hot flushes include SSRI and SNRI antidepressants, which enhance central serotonin and norepinephrine activity. Gabapentin has also proved to be effective.
Potential adverse events or negative side effects, such as insomnia, weight gain, drowsiness, and sedation, need to be taken into account when evaluating the benefits of pharmaceutical options.
There are no FDA-approved nonhormonal therapies for hot-flush reduction in breast cancer survivors.
Potentially effective drug therapies include clonidine, SSRIs, SNRIs, and gabapentin. Benefits need to be weighed carefully against side effects, because the reduction in absolute hot flushes is only mild to moderate.
Nonpharmaceutical therapies that are not beneficial include homeopathy, magnet therapy, and acupuncture. However, more recent RCT data suggest that, in breast cancer patients, traditional acupuncture (and, in some studies, sham acupuncture) may, in fact, significantly reduce frequency of hot flushes, with a prolonged reduction at 3 to 6 months.3,4 Relaxation therapy has a modest benefit.
When a patient reports bothersome hot flushes, I recommend that she avoid overheating, use cooling techniques, and try relaxation therapy or acupuncture.
For medical therapy, I usually recommend venlafaxine or gabapentin, both of which have an effect on hot flushes within 2 weeks and both of which are associated with side effects. I start with 37.5 mg of venlafaxine, increasing to 75 mg after 2 weeks, if needed. If using gabapentin, I start with 300 mg, increasing to 600 mg at night and adding 300 mg in the morning or afternoon, if needed, aiming for 900 to 1,800 mg per day.
For vaginal dryness, I recommend vaginal moisturizers (used twice weekly) and lubricants (as needed) for sexual activity. The use of vaginal dilators or topical estrogen therapy is individualized.—JOANN V. PINKERTON, MD
We want to hear from you! Tell us what you think.
1. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol. 1999;181(1):66-70.
2. Freedman RR. Core body temperature variation in symptomatic and asymptomatic postmenopausal women: brief report. Menopause. 2002;9(6):399-401.
3. Hervik J, Mialand O. Acupuncture for the treatment of hot flashes in breast cancer patients: a randomized, controlled trial. Breast Cancer Res Treat. 2009;116(2):311-316.
4. de Valois BA, Young TE, Robinson N, McCourt C, Maher EJ. Using traditional acupuncture for breast cancer-related hot flashes and night sweats. J Altern Complement Med. 2010;16(10):1047-1057.
1. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol. 1999;181(1):66-70.
2. Freedman RR. Core body temperature variation in symptomatic and asymptomatic postmenopausal women: brief report. Menopause. 2002;9(6):399-401.
3. Hervik J, Mialand O. Acupuncture for the treatment of hot flashes in breast cancer patients: a randomized, controlled trial. Breast Cancer Res Treat. 2009;116(2):311-316.
4. de Valois BA, Young TE, Robinson N, McCourt C, Maher EJ. Using traditional acupuncture for breast cancer-related hot flashes and night sweats. J Altern Complement Med. 2010;16(10):1047-1057.
ONLINE EXCLUSIVE: Audio interviews with experts in career advancement, training
Click here to listen to John Nelson, MD, MHM.
Click here to listen to Lakshmi Halasyamani, MD, SFHM.
Click here to listen to Win Whitcomb, MD, MHM.
Click here to listen to John Nelson, MD, MHM.
Click here to listen to Lakshmi Halasyamani, MD, SFHM.
Click here to listen to Win Whitcomb, MD, MHM.
Click here to listen to John Nelson, MD, MHM.
Click here to listen to Lakshmi Halasyamani, MD, SFHM.
Click here to listen to Win Whitcomb, MD, MHM.
Real Doctoring
Despite never advancing his musical tastes beyond the arena bands of the 1970s and ’80s (think Def Leppard), Mark Williams, MD, FACP, FHM, editor-in-chief of the Journal of Hospital Medicine, has done a great job in securing informative and meaningful research and opinion for the journal. Did you see read the July/August 2010 issue of JHM? It is a great example of content uniquely relevant to hospitalists: several original research articles documenting how hospitalists spend their time. Anyone thinking about the best way to organize and operate a hospitalist practice should read through these studies, along with one published by Kevin O’Leary, MD, and colleagues in the March/April 2006 issue.1 But as a service, I’ll provide a CliffsNotes version of them, along with some comments here.
Time-Motion Studies
What all the studies demonstrate is that academic hospitalists spend only about 15% to 20% of their time in direct patient care, generally defined as time spent taking a patient’s history and examination, meeting with families, etc. Indirect patient care, such as time spent reviewing records, documenting, and communicating with consultants and other patient care staff, consumes about 60% to 70% of their time. The remainder of time is spent in transit (around 7% of each day) and in personal activities.
Remember, all these studies reported on academic hospitalists in large academic medical centers. As noted in the discussion sections, the results in nonteaching community hospitals might be different. My guess is that community hospitalists spend about the same portion of time in the broad categories above, but the individual activities within each category might differ. So I’m willing to believe that these studies tell us something about the majority of hospitalists who practice outside of academia.
90 Minutes of Doctoring?
While the JHM studies assess hospitalist time in a number of different categories, I think it makes the most sense to divide our time into just two categories: “real doctoring” and other. We’ll probably never see a study that divides hospitalists’ time that way, as there would be endless debate about what is and isn’t real doctoring. But it is worth thinking about your work this way.
A lot of what the studies generally defined as indirect patient care is still “real doctoring.” Things like reviewing old records are critically important and typically can’t be done adequately by a nonclinician. But the 10 minutes you spent to get the CD of outside X-rays to show up on your computer, and rearranging the faxed pages so they’re all oriented the same way and in order, are not a good use of your time; a clerical person could do it.
I periodically have an experience that makes me think I spend too much time on patients’ social issues (e.g. long conversations about why Medicare won’t pay for a patient’s skilled nursing facility stay) and too little on “real doctoring.” One such experience is when I have a patient with an unusual pulmonary infiltrate and the radiologist is able to generate a much more comprehensive differential diagnosis than I can. This is embarrassing. Maybe the radiologist is just smarter than I am, but I think it could be because, compared to me, he spends more of his time every day thinking about “real medicine,” such as pulmonary diseases, and less time dealing with nonclinical issues.
Even though we’re paid for a full day’s work, I suspect many hospitalists might spend only about 90 minutes a day immersed in thought about “real medicine,” while doctors in most other specialties probably spend a lot more. If I’m right, then it shouldn’t be a surprise that after practicing for many years, the radiologist who spends several hours a day exercising his fund of medical knowledge probably has more command of some clinical things than a hospitalist who does so only 90 minutes a day. Actively practicing as a hospitalist might not be as effective a method of maintaining proficiency as it is in other specialties. More than many other specialties, we need to rely on self-study and continuing education courses to prevent erosion of our knowledge base.
I’ve just made up this 90-minute figure. I have no idea how accurate it might be, and, the JHM studies don’t offer a lot of insight either. Clearly, it varies a lot by individual doctor and practice setting. How much of your day do you think you spend on “real doctoring” vs. other activities?
What really matters is whether we’ve ended up with too much work that isn’t “real doctoring.” Sure, all of the work needs to be done, but the system isn’t served best when paying a doctor to do work a less expensive person could do.
Max “Doctoring” Time
I think most hospitalists, including me, are stuck spending too much time on activities that don’t add value. For example, while complete and informative documentation is essential, most of us probably spend too much time on it, in part because we’re trying to immunize against lawsuits and ensure our documentation matches the relevant coding regulations.
I think hospitalists have a communication burden that is higher than that of most other specialties. The JHM article by Tipping and colleagues notes that a time-motion study of ED doctors (Ann Emerg Med. 1998:31(1):87-91) found that they spent 13% of their time communicating with other providers and staff, compared with their finding that hospitalists spent 26% of their time communicating.2 Only a portion of this communication is real doctoring. Discussing patient management with a surgeon is, but spending 20 minutes figuring out which surgeon is on call and how to reach her isn’t.
Tipping’s study also found that when patient census was above average, hospitalists spent less time communicating and documenting in the electronic record, even though the total time spent working on those days increased. Of course, it is possible that when the patient census is below average, we just work more slowly and let work fill the time available, and the reduced time spent documenting and communicating when busy simply reflects working more efficiently. But I suspect that when our patient census climbs above a certain point, or we’re made less efficient by things like implementing a new technology, we compensate in part by relying on consultants more to do the real doctoring we would otherwise be doing and communicating with them less.
All of us should be thinking about ways to make communication as efficient as possible so that we can spend less time doing it. I’m hopeful that we will figure out new ways to communicate (e-mail, text, IM, etc.) that are quicker and just as effective in certain situations.
Coda
I try to write most of my columns in a way that minimizes the editorializing and maximizes the practical advice. This month is an exception; it’s all editorializing. But I do have some advice for Dr. Williams: Investigate music options other than the arena bands of the 1980s. Try something like Alison Krauss’ live album or Puccini’s opera Gianni Schicchi, which has the beautiful aria O mio babbino caro.
Or do what I do: Ask former SHM board member Brad Flansbaum, MD, SFHM, for advice. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.
References
- O’Leary KJ, Liebovitz DM, Baker DW. How hospitalists spend their time: insights on efficiency and safety. J Hosp Med. 2006;1(2):88-93.
- Tipping MD, Forth VE, O’Leary KJ, et al. Where did the day go? A time-motion study of hospitalists. J Hosp Med. 2010;5(6):323-328.
Despite never advancing his musical tastes beyond the arena bands of the 1970s and ’80s (think Def Leppard), Mark Williams, MD, FACP, FHM, editor-in-chief of the Journal of Hospital Medicine, has done a great job in securing informative and meaningful research and opinion for the journal. Did you see read the July/August 2010 issue of JHM? It is a great example of content uniquely relevant to hospitalists: several original research articles documenting how hospitalists spend their time. Anyone thinking about the best way to organize and operate a hospitalist practice should read through these studies, along with one published by Kevin O’Leary, MD, and colleagues in the March/April 2006 issue.1 But as a service, I’ll provide a CliffsNotes version of them, along with some comments here.
Time-Motion Studies
What all the studies demonstrate is that academic hospitalists spend only about 15% to 20% of their time in direct patient care, generally defined as time spent taking a patient’s history and examination, meeting with families, etc. Indirect patient care, such as time spent reviewing records, documenting, and communicating with consultants and other patient care staff, consumes about 60% to 70% of their time. The remainder of time is spent in transit (around 7% of each day) and in personal activities.
Remember, all these studies reported on academic hospitalists in large academic medical centers. As noted in the discussion sections, the results in nonteaching community hospitals might be different. My guess is that community hospitalists spend about the same portion of time in the broad categories above, but the individual activities within each category might differ. So I’m willing to believe that these studies tell us something about the majority of hospitalists who practice outside of academia.
90 Minutes of Doctoring?
While the JHM studies assess hospitalist time in a number of different categories, I think it makes the most sense to divide our time into just two categories: “real doctoring” and other. We’ll probably never see a study that divides hospitalists’ time that way, as there would be endless debate about what is and isn’t real doctoring. But it is worth thinking about your work this way.
A lot of what the studies generally defined as indirect patient care is still “real doctoring.” Things like reviewing old records are critically important and typically can’t be done adequately by a nonclinician. But the 10 minutes you spent to get the CD of outside X-rays to show up on your computer, and rearranging the faxed pages so they’re all oriented the same way and in order, are not a good use of your time; a clerical person could do it.
I periodically have an experience that makes me think I spend too much time on patients’ social issues (e.g. long conversations about why Medicare won’t pay for a patient’s skilled nursing facility stay) and too little on “real doctoring.” One such experience is when I have a patient with an unusual pulmonary infiltrate and the radiologist is able to generate a much more comprehensive differential diagnosis than I can. This is embarrassing. Maybe the radiologist is just smarter than I am, but I think it could be because, compared to me, he spends more of his time every day thinking about “real medicine,” such as pulmonary diseases, and less time dealing with nonclinical issues.
Even though we’re paid for a full day’s work, I suspect many hospitalists might spend only about 90 minutes a day immersed in thought about “real medicine,” while doctors in most other specialties probably spend a lot more. If I’m right, then it shouldn’t be a surprise that after practicing for many years, the radiologist who spends several hours a day exercising his fund of medical knowledge probably has more command of some clinical things than a hospitalist who does so only 90 minutes a day. Actively practicing as a hospitalist might not be as effective a method of maintaining proficiency as it is in other specialties. More than many other specialties, we need to rely on self-study and continuing education courses to prevent erosion of our knowledge base.
I’ve just made up this 90-minute figure. I have no idea how accurate it might be, and, the JHM studies don’t offer a lot of insight either. Clearly, it varies a lot by individual doctor and practice setting. How much of your day do you think you spend on “real doctoring” vs. other activities?
What really matters is whether we’ve ended up with too much work that isn’t “real doctoring.” Sure, all of the work needs to be done, but the system isn’t served best when paying a doctor to do work a less expensive person could do.
Max “Doctoring” Time
I think most hospitalists, including me, are stuck spending too much time on activities that don’t add value. For example, while complete and informative documentation is essential, most of us probably spend too much time on it, in part because we’re trying to immunize against lawsuits and ensure our documentation matches the relevant coding regulations.
I think hospitalists have a communication burden that is higher than that of most other specialties. The JHM article by Tipping and colleagues notes that a time-motion study of ED doctors (Ann Emerg Med. 1998:31(1):87-91) found that they spent 13% of their time communicating with other providers and staff, compared with their finding that hospitalists spent 26% of their time communicating.2 Only a portion of this communication is real doctoring. Discussing patient management with a surgeon is, but spending 20 minutes figuring out which surgeon is on call and how to reach her isn’t.
Tipping’s study also found that when patient census was above average, hospitalists spent less time communicating and documenting in the electronic record, even though the total time spent working on those days increased. Of course, it is possible that when the patient census is below average, we just work more slowly and let work fill the time available, and the reduced time spent documenting and communicating when busy simply reflects working more efficiently. But I suspect that when our patient census climbs above a certain point, or we’re made less efficient by things like implementing a new technology, we compensate in part by relying on consultants more to do the real doctoring we would otherwise be doing and communicating with them less.
All of us should be thinking about ways to make communication as efficient as possible so that we can spend less time doing it. I’m hopeful that we will figure out new ways to communicate (e-mail, text, IM, etc.) that are quicker and just as effective in certain situations.
Coda
I try to write most of my columns in a way that minimizes the editorializing and maximizes the practical advice. This month is an exception; it’s all editorializing. But I do have some advice for Dr. Williams: Investigate music options other than the arena bands of the 1980s. Try something like Alison Krauss’ live album or Puccini’s opera Gianni Schicchi, which has the beautiful aria O mio babbino caro.
Or do what I do: Ask former SHM board member Brad Flansbaum, MD, SFHM, for advice. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.
References
- O’Leary KJ, Liebovitz DM, Baker DW. How hospitalists spend their time: insights on efficiency and safety. J Hosp Med. 2006;1(2):88-93.
- Tipping MD, Forth VE, O’Leary KJ, et al. Where did the day go? A time-motion study of hospitalists. J Hosp Med. 2010;5(6):323-328.
Despite never advancing his musical tastes beyond the arena bands of the 1970s and ’80s (think Def Leppard), Mark Williams, MD, FACP, FHM, editor-in-chief of the Journal of Hospital Medicine, has done a great job in securing informative and meaningful research and opinion for the journal. Did you see read the July/August 2010 issue of JHM? It is a great example of content uniquely relevant to hospitalists: several original research articles documenting how hospitalists spend their time. Anyone thinking about the best way to organize and operate a hospitalist practice should read through these studies, along with one published by Kevin O’Leary, MD, and colleagues in the March/April 2006 issue.1 But as a service, I’ll provide a CliffsNotes version of them, along with some comments here.
Time-Motion Studies
What all the studies demonstrate is that academic hospitalists spend only about 15% to 20% of their time in direct patient care, generally defined as time spent taking a patient’s history and examination, meeting with families, etc. Indirect patient care, such as time spent reviewing records, documenting, and communicating with consultants and other patient care staff, consumes about 60% to 70% of their time. The remainder of time is spent in transit (around 7% of each day) and in personal activities.
Remember, all these studies reported on academic hospitalists in large academic medical centers. As noted in the discussion sections, the results in nonteaching community hospitals might be different. My guess is that community hospitalists spend about the same portion of time in the broad categories above, but the individual activities within each category might differ. So I’m willing to believe that these studies tell us something about the majority of hospitalists who practice outside of academia.
90 Minutes of Doctoring?
While the JHM studies assess hospitalist time in a number of different categories, I think it makes the most sense to divide our time into just two categories: “real doctoring” and other. We’ll probably never see a study that divides hospitalists’ time that way, as there would be endless debate about what is and isn’t real doctoring. But it is worth thinking about your work this way.
A lot of what the studies generally defined as indirect patient care is still “real doctoring.” Things like reviewing old records are critically important and typically can’t be done adequately by a nonclinician. But the 10 minutes you spent to get the CD of outside X-rays to show up on your computer, and rearranging the faxed pages so they’re all oriented the same way and in order, are not a good use of your time; a clerical person could do it.
I periodically have an experience that makes me think I spend too much time on patients’ social issues (e.g. long conversations about why Medicare won’t pay for a patient’s skilled nursing facility stay) and too little on “real doctoring.” One such experience is when I have a patient with an unusual pulmonary infiltrate and the radiologist is able to generate a much more comprehensive differential diagnosis than I can. This is embarrassing. Maybe the radiologist is just smarter than I am, but I think it could be because, compared to me, he spends more of his time every day thinking about “real medicine,” such as pulmonary diseases, and less time dealing with nonclinical issues.
Even though we’re paid for a full day’s work, I suspect many hospitalists might spend only about 90 minutes a day immersed in thought about “real medicine,” while doctors in most other specialties probably spend a lot more. If I’m right, then it shouldn’t be a surprise that after practicing for many years, the radiologist who spends several hours a day exercising his fund of medical knowledge probably has more command of some clinical things than a hospitalist who does so only 90 minutes a day. Actively practicing as a hospitalist might not be as effective a method of maintaining proficiency as it is in other specialties. More than many other specialties, we need to rely on self-study and continuing education courses to prevent erosion of our knowledge base.
I’ve just made up this 90-minute figure. I have no idea how accurate it might be, and, the JHM studies don’t offer a lot of insight either. Clearly, it varies a lot by individual doctor and practice setting. How much of your day do you think you spend on “real doctoring” vs. other activities?
What really matters is whether we’ve ended up with too much work that isn’t “real doctoring.” Sure, all of the work needs to be done, but the system isn’t served best when paying a doctor to do work a less expensive person could do.
Max “Doctoring” Time
I think most hospitalists, including me, are stuck spending too much time on activities that don’t add value. For example, while complete and informative documentation is essential, most of us probably spend too much time on it, in part because we’re trying to immunize against lawsuits and ensure our documentation matches the relevant coding regulations.
I think hospitalists have a communication burden that is higher than that of most other specialties. The JHM article by Tipping and colleagues notes that a time-motion study of ED doctors (Ann Emerg Med. 1998:31(1):87-91) found that they spent 13% of their time communicating with other providers and staff, compared with their finding that hospitalists spent 26% of their time communicating.2 Only a portion of this communication is real doctoring. Discussing patient management with a surgeon is, but spending 20 minutes figuring out which surgeon is on call and how to reach her isn’t.
Tipping’s study also found that when patient census was above average, hospitalists spent less time communicating and documenting in the electronic record, even though the total time spent working on those days increased. Of course, it is possible that when the patient census is below average, we just work more slowly and let work fill the time available, and the reduced time spent documenting and communicating when busy simply reflects working more efficiently. But I suspect that when our patient census climbs above a certain point, or we’re made less efficient by things like implementing a new technology, we compensate in part by relying on consultants more to do the real doctoring we would otherwise be doing and communicating with them less.
All of us should be thinking about ways to make communication as efficient as possible so that we can spend less time doing it. I’m hopeful that we will figure out new ways to communicate (e-mail, text, IM, etc.) that are quicker and just as effective in certain situations.
Coda
I try to write most of my columns in a way that minimizes the editorializing and maximizes the practical advice. This month is an exception; it’s all editorializing. But I do have some advice for Dr. Williams: Investigate music options other than the arena bands of the 1980s. Try something like Alison Krauss’ live album or Puccini’s opera Gianni Schicchi, which has the beautiful aria O mio babbino caro.
Or do what I do: Ask former SHM board member Brad Flansbaum, MD, SFHM, for advice. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.
References
- O’Leary KJ, Liebovitz DM, Baker DW. How hospitalists spend their time: insights on efficiency and safety. J Hosp Med. 2006;1(2):88-93.
- Tipping MD, Forth VE, O’Leary KJ, et al. Where did the day go? A time-motion study of hospitalists. J Hosp Med. 2010;5(6):323-328.
Is there a link between cerebral palsy and chorioamnionitis?
Read Dr. Robert L. Barbieri’s November 2010 editorial on therapeutic hypothermia for newborns
CP is heterogeneous in both its clinical manifestations and its causation. It is now clear that no more than 10% of all cases result from intrapartum injury.1-3 The vast majority of cases (>90%) arise from circumstances unrelated to labor. Among the variables associated with CP are antepartum entities such as developmental abnormality, metabolic derangement, genetic disorders, infection or inflammation, antepartum hemorrhage (with or without a recognized coagulation disorder), and autoimmune disease. Even postnatal events within the first few years of life may be implicated, including complications of prematurity or postmaturity, trauma, and infection.
It has long been known from case series, case-control studies, cohort studies, and at least two earlier meta-analyses4,5 that a diagnosis of intrauterine infection (chorioamnionitis) during pregnancy—whether made by clinical examination, histologic examination of the placenta, or amniotic fluid culture—is associated with an increased risk of CP. (These data are reviewed in a joint statement by ACOG and the American Academy of Pediatrics on the pathogenesis of neonatal encephalopathy and CP.2)
This new meta-analysis by Shatrov and colleagues confirms the association between chorioamnionitis and CP. Other than that, it adds little to the existing literature and provides no additional information for clinicians on how to manage high-risk patients.
Inflammation may be the real culprit
The association between intrauterine infection and neurologic injury in offspring (including CP) is almost certainly causal. Using a rabbit model, Yoon and coworkers demonstrated that intrauterine infection leads to white matter lesions in the fetal brain that closely resemble the lesions of infection-associated CP seen in the human infant.6 Similar observations have been made in mice and pigs.
The mechanisms underlying these end-organ injuries are not well understood, but the weight of evidence suggests that they are an indirect result of the pro-inflammatory cascade triggered to subdue the infection, rather than a direct effect of the infectious organisms themselves.7,8 Therefore, it may be more accurate to refer to an association between CP and intra-amniotic inflammation rather than intra-amniotic infection.
Increasing evidence suggests that it is low-grade chronic inflammation that leads to neurologic injury rather than acute infection.9,10 Clinicians should find this evidence reassuring because it suggests that we are doing our patients no harm when we recommend, for example, expectant management for ruptured membranes remote from term or induction of labor rather than urgent cesarean in the setting of confirmed intraamniotic infection.
Can CP be prevented?
A number of interventions have been proposed in an effort to prevent CP, with variable results. They include selective administration of antenatal corticosteroids or magnesium sulfate, elective cesarean delivery, and neonatal hypothermia therapy. Broad-spectrum antibiotics are routinely administered to women who have intra-amniotic infection, primarily to prevent the spread of infection beyond the uterus. If intrauterine infection is causally related to brain injury, can such antibiotic therapy prevent CP?
There is no evidence that antibiotics can protect against neurologic injury. In fact, antibiotics can be detrimental, according to a recent 7-year follow-up of the ORACLE-II randomized clinical trial, which was designed to investigate the effect of broad-spectrum antibiotics on perinatal outcome in women who have preterm labor and intact membranes.11 In this study, fetuses exposed to broad-spectrum antibiotics had a significantly higher risk of CP at age 7 years, with an adjusted odds ratio (OR) of 1.93 for erythromycin (95% CI, 1.21–3.09) and 1.69 for co-amoxiclav (95% CI, 1.07–2.67). Fetuses randomized to receive both antibiotics had an even higher risk of CP. The incidence of CP was 4.55% among these fetuses, compared with 1.97% among those receiving co-amoxiclav alone, 2.29% for those receiving erythromycin alone, and 1.63% for those randomized to the placebo group.
The mechanism of injury is not clear, but it may be that antibiotics may suppress infection and delay delivery, thereby prolonging the fetus’s sojourn in a hostile, pro-inflammatory intrauterine milieu.
If neurologic injury is indeed the result of inflammation rather than infection, then anti-inflammatory agents, such as corticosteroids, cyclooxygenase inhibitors, and N-acetylcysteine—alone or in combination with antibiotics—may prevent neurologic injury in the setting of intrauterine infection. Studies into this possibility are under way, and the results are eagerly awaited.
Although intrauterine infection is almost certainly a cause of CP, the mechanism of injury is likely indirect and a result of the activation of the pro-inflammatory cascade rather than the presence of the infectious organisms themselves. Moreover, it is chronic low-grade inflammation rather than acute infection that seems to be the major culprit.
For these reasons, physicians should not alter current clinical practices such as expectant management for ruptured membranes remote from term, or induction of labor (rather than urgent cesarean) when infection is confirmed. Broad-spectrum antibiotics should be administered in the setting of intra-amniotic infection, with delivery following (primarily to prevent the infection from spreading outside of the uterus), but antibiotic therapy does not appear to prevent neurologic injury and may even be detrimental. Taken together, these data suggest we should maintain the status quo until further studies illuminate more effective alternatives.
—ERROL R. NORWITZ, MD, PHD
We want to hear from you! Tell us what you think.
1. MacLennan A. for the International Cerebral Palsy Task Force. A template for defining a causal relation between acute intrapartum events and cerebral palsy: International consensus statement. Br Med J. 1999;319(7216):1054-1059.
2. ACOG Task Force on Neonatal Encephalopathy and Cerebral Palsy. Neonatal encephalopathy and cerebral palsy: Defining the pathogenesis and pathophysiology. Washington, DC: ACOG; 2003.
3. Hankins GD, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol. 2003;102(3):628-636.
4. Wu YW, Colford JM, Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA. 2000;284(11):1417.-
5. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev. 2002;8(1):25-29.
6. Yoon BH, Kim CJ, Romero R, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 1997;177(4):797-802.
7. Dammann O, Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr. 2000;12(2):99-104.
8. Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med. 2006;34(1):5-12.
9. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000;182(3):675-681.
10. Andrews WW, Cliver SP, Biasini F, et al. Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol. 2008;198(4):466.e1-11.
11. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372(9646):1319-1327.
Read Dr. Robert L. Barbieri’s November 2010 editorial on therapeutic hypothermia for newborns
CP is heterogeneous in both its clinical manifestations and its causation. It is now clear that no more than 10% of all cases result from intrapartum injury.1-3 The vast majority of cases (>90%) arise from circumstances unrelated to labor. Among the variables associated with CP are antepartum entities such as developmental abnormality, metabolic derangement, genetic disorders, infection or inflammation, antepartum hemorrhage (with or without a recognized coagulation disorder), and autoimmune disease. Even postnatal events within the first few years of life may be implicated, including complications of prematurity or postmaturity, trauma, and infection.
It has long been known from case series, case-control studies, cohort studies, and at least two earlier meta-analyses4,5 that a diagnosis of intrauterine infection (chorioamnionitis) during pregnancy—whether made by clinical examination, histologic examination of the placenta, or amniotic fluid culture—is associated with an increased risk of CP. (These data are reviewed in a joint statement by ACOG and the American Academy of Pediatrics on the pathogenesis of neonatal encephalopathy and CP.2)
This new meta-analysis by Shatrov and colleagues confirms the association between chorioamnionitis and CP. Other than that, it adds little to the existing literature and provides no additional information for clinicians on how to manage high-risk patients.
Inflammation may be the real culprit
The association between intrauterine infection and neurologic injury in offspring (including CP) is almost certainly causal. Using a rabbit model, Yoon and coworkers demonstrated that intrauterine infection leads to white matter lesions in the fetal brain that closely resemble the lesions of infection-associated CP seen in the human infant.6 Similar observations have been made in mice and pigs.
The mechanisms underlying these end-organ injuries are not well understood, but the weight of evidence suggests that they are an indirect result of the pro-inflammatory cascade triggered to subdue the infection, rather than a direct effect of the infectious organisms themselves.7,8 Therefore, it may be more accurate to refer to an association between CP and intra-amniotic inflammation rather than intra-amniotic infection.
Increasing evidence suggests that it is low-grade chronic inflammation that leads to neurologic injury rather than acute infection.9,10 Clinicians should find this evidence reassuring because it suggests that we are doing our patients no harm when we recommend, for example, expectant management for ruptured membranes remote from term or induction of labor rather than urgent cesarean in the setting of confirmed intraamniotic infection.
Can CP be prevented?
A number of interventions have been proposed in an effort to prevent CP, with variable results. They include selective administration of antenatal corticosteroids or magnesium sulfate, elective cesarean delivery, and neonatal hypothermia therapy. Broad-spectrum antibiotics are routinely administered to women who have intra-amniotic infection, primarily to prevent the spread of infection beyond the uterus. If intrauterine infection is causally related to brain injury, can such antibiotic therapy prevent CP?
There is no evidence that antibiotics can protect against neurologic injury. In fact, antibiotics can be detrimental, according to a recent 7-year follow-up of the ORACLE-II randomized clinical trial, which was designed to investigate the effect of broad-spectrum antibiotics on perinatal outcome in women who have preterm labor and intact membranes.11 In this study, fetuses exposed to broad-spectrum antibiotics had a significantly higher risk of CP at age 7 years, with an adjusted odds ratio (OR) of 1.93 for erythromycin (95% CI, 1.21–3.09) and 1.69 for co-amoxiclav (95% CI, 1.07–2.67). Fetuses randomized to receive both antibiotics had an even higher risk of CP. The incidence of CP was 4.55% among these fetuses, compared with 1.97% among those receiving co-amoxiclav alone, 2.29% for those receiving erythromycin alone, and 1.63% for those randomized to the placebo group.
The mechanism of injury is not clear, but it may be that antibiotics may suppress infection and delay delivery, thereby prolonging the fetus’s sojourn in a hostile, pro-inflammatory intrauterine milieu.
If neurologic injury is indeed the result of inflammation rather than infection, then anti-inflammatory agents, such as corticosteroids, cyclooxygenase inhibitors, and N-acetylcysteine—alone or in combination with antibiotics—may prevent neurologic injury in the setting of intrauterine infection. Studies into this possibility are under way, and the results are eagerly awaited.
Although intrauterine infection is almost certainly a cause of CP, the mechanism of injury is likely indirect and a result of the activation of the pro-inflammatory cascade rather than the presence of the infectious organisms themselves. Moreover, it is chronic low-grade inflammation rather than acute infection that seems to be the major culprit.
For these reasons, physicians should not alter current clinical practices such as expectant management for ruptured membranes remote from term, or induction of labor (rather than urgent cesarean) when infection is confirmed. Broad-spectrum antibiotics should be administered in the setting of intra-amniotic infection, with delivery following (primarily to prevent the infection from spreading outside of the uterus), but antibiotic therapy does not appear to prevent neurologic injury and may even be detrimental. Taken together, these data suggest we should maintain the status quo until further studies illuminate more effective alternatives.
—ERROL R. NORWITZ, MD, PHD
We want to hear from you! Tell us what you think.
Read Dr. Robert L. Barbieri’s November 2010 editorial on therapeutic hypothermia for newborns
CP is heterogeneous in both its clinical manifestations and its causation. It is now clear that no more than 10% of all cases result from intrapartum injury.1-3 The vast majority of cases (>90%) arise from circumstances unrelated to labor. Among the variables associated with CP are antepartum entities such as developmental abnormality, metabolic derangement, genetic disorders, infection or inflammation, antepartum hemorrhage (with or without a recognized coagulation disorder), and autoimmune disease. Even postnatal events within the first few years of life may be implicated, including complications of prematurity or postmaturity, trauma, and infection.
It has long been known from case series, case-control studies, cohort studies, and at least two earlier meta-analyses4,5 that a diagnosis of intrauterine infection (chorioamnionitis) during pregnancy—whether made by clinical examination, histologic examination of the placenta, or amniotic fluid culture—is associated with an increased risk of CP. (These data are reviewed in a joint statement by ACOG and the American Academy of Pediatrics on the pathogenesis of neonatal encephalopathy and CP.2)
This new meta-analysis by Shatrov and colleagues confirms the association between chorioamnionitis and CP. Other than that, it adds little to the existing literature and provides no additional information for clinicians on how to manage high-risk patients.
Inflammation may be the real culprit
The association between intrauterine infection and neurologic injury in offspring (including CP) is almost certainly causal. Using a rabbit model, Yoon and coworkers demonstrated that intrauterine infection leads to white matter lesions in the fetal brain that closely resemble the lesions of infection-associated CP seen in the human infant.6 Similar observations have been made in mice and pigs.
The mechanisms underlying these end-organ injuries are not well understood, but the weight of evidence suggests that they are an indirect result of the pro-inflammatory cascade triggered to subdue the infection, rather than a direct effect of the infectious organisms themselves.7,8 Therefore, it may be more accurate to refer to an association between CP and intra-amniotic inflammation rather than intra-amniotic infection.
Increasing evidence suggests that it is low-grade chronic inflammation that leads to neurologic injury rather than acute infection.9,10 Clinicians should find this evidence reassuring because it suggests that we are doing our patients no harm when we recommend, for example, expectant management for ruptured membranes remote from term or induction of labor rather than urgent cesarean in the setting of confirmed intraamniotic infection.
Can CP be prevented?
A number of interventions have been proposed in an effort to prevent CP, with variable results. They include selective administration of antenatal corticosteroids or magnesium sulfate, elective cesarean delivery, and neonatal hypothermia therapy. Broad-spectrum antibiotics are routinely administered to women who have intra-amniotic infection, primarily to prevent the spread of infection beyond the uterus. If intrauterine infection is causally related to brain injury, can such antibiotic therapy prevent CP?
There is no evidence that antibiotics can protect against neurologic injury. In fact, antibiotics can be detrimental, according to a recent 7-year follow-up of the ORACLE-II randomized clinical trial, which was designed to investigate the effect of broad-spectrum antibiotics on perinatal outcome in women who have preterm labor and intact membranes.11 In this study, fetuses exposed to broad-spectrum antibiotics had a significantly higher risk of CP at age 7 years, with an adjusted odds ratio (OR) of 1.93 for erythromycin (95% CI, 1.21–3.09) and 1.69 for co-amoxiclav (95% CI, 1.07–2.67). Fetuses randomized to receive both antibiotics had an even higher risk of CP. The incidence of CP was 4.55% among these fetuses, compared with 1.97% among those receiving co-amoxiclav alone, 2.29% for those receiving erythromycin alone, and 1.63% for those randomized to the placebo group.
The mechanism of injury is not clear, but it may be that antibiotics may suppress infection and delay delivery, thereby prolonging the fetus’s sojourn in a hostile, pro-inflammatory intrauterine milieu.
If neurologic injury is indeed the result of inflammation rather than infection, then anti-inflammatory agents, such as corticosteroids, cyclooxygenase inhibitors, and N-acetylcysteine—alone or in combination with antibiotics—may prevent neurologic injury in the setting of intrauterine infection. Studies into this possibility are under way, and the results are eagerly awaited.
Although intrauterine infection is almost certainly a cause of CP, the mechanism of injury is likely indirect and a result of the activation of the pro-inflammatory cascade rather than the presence of the infectious organisms themselves. Moreover, it is chronic low-grade inflammation rather than acute infection that seems to be the major culprit.
For these reasons, physicians should not alter current clinical practices such as expectant management for ruptured membranes remote from term, or induction of labor (rather than urgent cesarean) when infection is confirmed. Broad-spectrum antibiotics should be administered in the setting of intra-amniotic infection, with delivery following (primarily to prevent the infection from spreading outside of the uterus), but antibiotic therapy does not appear to prevent neurologic injury and may even be detrimental. Taken together, these data suggest we should maintain the status quo until further studies illuminate more effective alternatives.
—ERROL R. NORWITZ, MD, PHD
We want to hear from you! Tell us what you think.
1. MacLennan A. for the International Cerebral Palsy Task Force. A template for defining a causal relation between acute intrapartum events and cerebral palsy: International consensus statement. Br Med J. 1999;319(7216):1054-1059.
2. ACOG Task Force on Neonatal Encephalopathy and Cerebral Palsy. Neonatal encephalopathy and cerebral palsy: Defining the pathogenesis and pathophysiology. Washington, DC: ACOG; 2003.
3. Hankins GD, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol. 2003;102(3):628-636.
4. Wu YW, Colford JM, Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA. 2000;284(11):1417.-
5. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev. 2002;8(1):25-29.
6. Yoon BH, Kim CJ, Romero R, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 1997;177(4):797-802.
7. Dammann O, Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr. 2000;12(2):99-104.
8. Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med. 2006;34(1):5-12.
9. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000;182(3):675-681.
10. Andrews WW, Cliver SP, Biasini F, et al. Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol. 2008;198(4):466.e1-11.
11. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372(9646):1319-1327.
1. MacLennan A. for the International Cerebral Palsy Task Force. A template for defining a causal relation between acute intrapartum events and cerebral palsy: International consensus statement. Br Med J. 1999;319(7216):1054-1059.
2. ACOG Task Force on Neonatal Encephalopathy and Cerebral Palsy. Neonatal encephalopathy and cerebral palsy: Defining the pathogenesis and pathophysiology. Washington, DC: ACOG; 2003.
3. Hankins GD, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol. 2003;102(3):628-636.
4. Wu YW, Colford JM, Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA. 2000;284(11):1417.-
5. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev. 2002;8(1):25-29.
6. Yoon BH, Kim CJ, Romero R, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 1997;177(4):797-802.
7. Dammann O, Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr. 2000;12(2):99-104.
8. Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med. 2006;34(1):5-12.
9. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000;182(3):675-681.
10. Andrews WW, Cliver SP, Biasini F, et al. Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol. 2008;198(4):466.e1-11.
11. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372(9646):1319-1327.
Toxic Employees
The providers in every hospitalist practice should be a good fit for the practice’s culture. They should have reasonable relationships with their colleagues in the practice, patients and families, and other staff at the hospital.
I can’t imagine anyone arguing with this point of view. But in my work with hundreds of hospitalist practices over the past 15 years, I’ve found that many practices seem to have a hard time ensuring their providers meet that standard. I can think of lots of reasons for this. The first that comes to mind is the difficult HM recruiting environment. Almost all hospitalist practices needed to grow quickly, and many lowered the bar in the qualifications and the fit of the candidates they hired to make sure they filled all of their positions.
Even if it later becomes clear a provider isn’t a good fit for the group culture, or worse still lacks the knowledge base and judgment to perform well, many practices are reluctant to replace the hospitalist because it might be difficult to find a replacement—and there is no guarantee the new person will perform any better. Because of this, a number of practices have ended up with providers who in many cases have a negative influence on others in the practice, and both the practice and the problem provider would be better off if the provider went elsewhere.
The Problem Physician
To their credit, most practices do act when a provider simply lacks the skill and judgment to perform adequately. This can mean close proctoring/mentoring for an extended period, or requiring specific CME course work to correct a skill that is lacking. But it also means reassigning the person to a different job, or termination.
But in the case of someone with a toxic personality, practices often are more reluctant to act. I’ll often hear the leadership of a practice say something like, “We knew Alice wasn’t a good fit for our practice within a few weeks of her start date.” The start date was several years ago and nothing has been done about this. Not surprisingly, Alice still performs poorly.
I’m not talking about someone who has occasional problems. I’m talking about people who cause problems almost every time they show up to work. Here are some real anecdotes, with fictitious names to ensure anonymity for the person and institution:
- Dr. Lee routinely disappears for several hours, during which he doesn’t answer pages. This even happens when he is the only doctor covering the practice.
- Dr. Lifeson, while generally getting along well with his fellow hospitalists and the nursing staff, can be counted on to complain bitterly about all levels of the hospital administration and leadership. He never misses an opportunity to try to convince other hospitalists that the leadership is not only inept, but also clearly has a malicious intent toward hospitalists.
- Dr. Peart complains incessantly about even tiny inequities in the work schedule or patient load. Others in the group have found that it is easier to ensure he always has the best schedule and lightest patient load, hoping they won’t have to hear his constant complaining. But even that hasn’t stemmed the steady downpour of negativity from him.
In all three of these cases, it seemed clear that the doctor should be terminated. And while the practice leadership agreed with me, they offered several excuses for why they hadn’t taken this step.
- “Who knows if we can find a replacement who will be any better?”
- “But he’s actually a decent doctor and doesn’t get a lot of complaints from patients.”
- “He’s such an angry guy, we worry about litigation if we fire him.”
I can’t offer any clear rule about when a practice should stop trying to improve a provider’s behavior and recognize that it is time to terminate the provider. But it is worth remembering that waiting too long has many costs, including the satisfaction of others in the group. Everyone will think less of the practice they are part of if poor behavior is tolerated.
Assess the Situation, Then Take Action
Most doctors who serve as the lead physician for their group have little or no experience dealing with problem behavior, let alone experience ensuring that necessary steps are followed prior to disciplining or terminating someone. But every hospital has someone who is very knowledgeable about these things; they should be engaged for advice, and, in the case of hospital-employed groups, should participate in the process of counseling and/or termination. It is important to take advantage of the expertise that is available.
Of course, the best approach is to prevent such problems from coming up. The best way to do this is to be very careful when hiring new providers. Checking references carefully is probably the best way to get an idea about whether someone might have behavior or personality problems. There are “job fit” survey instruments that you can use, but I’m not sure how effective they are, or how much value they add for a hospitalist practice beyond other means of assessing the candidate. And in the process of hiring someone, be sure to set behavior expectations very clearly. A new candidate should know that you will not tolerate not living up to behavioral expectations.
When dealing with bad behavior, make sure that you follow a careful and well-documented process. If someone still makes it through the hiring process only to be revealed as a troublemaker soon after their start date, don’t wait to sit that person down for very clear counseling; insist that their behavior change. Take notes of each meeting, and consider having the problem doctor sign and date the notes. While it might be easier to just wait and see if the first instance of bad behavior was an anomaly, that usually is a bad idea.
You should consider bringing the problem provider into the tent. The root of some bad behavior (i.e. criticism of leadership) is a person’s insecurity and lack of a feeling of ownership or control of their role in the practice. In that case, it might be reasonable to invite such a person into a role of greater responsibility in the practice so that they feel more in control. For example, a doctor who constantly complains about the work schedule might be invited to join the group’s executive committee or take on some other formal leadership role in the practice. This could backfire, so it should be tried only in carefully selected cases, and with the problem doctor’s clear understanding that they are being given a chance to have a bigger role in the practice but must improve their behavior or face serious consequences that could include termination.
I have seen this work beautifully in some cases, curing the problem behavior and turning the doctor into a valuable asset. I only wish there were a reliable way to know when to try this strategy. Sadly, it just requires judgment and intuition. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.
The providers in every hospitalist practice should be a good fit for the practice’s culture. They should have reasonable relationships with their colleagues in the practice, patients and families, and other staff at the hospital.
I can’t imagine anyone arguing with this point of view. But in my work with hundreds of hospitalist practices over the past 15 years, I’ve found that many practices seem to have a hard time ensuring their providers meet that standard. I can think of lots of reasons for this. The first that comes to mind is the difficult HM recruiting environment. Almost all hospitalist practices needed to grow quickly, and many lowered the bar in the qualifications and the fit of the candidates they hired to make sure they filled all of their positions.
Even if it later becomes clear a provider isn’t a good fit for the group culture, or worse still lacks the knowledge base and judgment to perform well, many practices are reluctant to replace the hospitalist because it might be difficult to find a replacement—and there is no guarantee the new person will perform any better. Because of this, a number of practices have ended up with providers who in many cases have a negative influence on others in the practice, and both the practice and the problem provider would be better off if the provider went elsewhere.
The Problem Physician
To their credit, most practices do act when a provider simply lacks the skill and judgment to perform adequately. This can mean close proctoring/mentoring for an extended period, or requiring specific CME course work to correct a skill that is lacking. But it also means reassigning the person to a different job, or termination.
But in the case of someone with a toxic personality, practices often are more reluctant to act. I’ll often hear the leadership of a practice say something like, “We knew Alice wasn’t a good fit for our practice within a few weeks of her start date.” The start date was several years ago and nothing has been done about this. Not surprisingly, Alice still performs poorly.
I’m not talking about someone who has occasional problems. I’m talking about people who cause problems almost every time they show up to work. Here are some real anecdotes, with fictitious names to ensure anonymity for the person and institution:
- Dr. Lee routinely disappears for several hours, during which he doesn’t answer pages. This even happens when he is the only doctor covering the practice.
- Dr. Lifeson, while generally getting along well with his fellow hospitalists and the nursing staff, can be counted on to complain bitterly about all levels of the hospital administration and leadership. He never misses an opportunity to try to convince other hospitalists that the leadership is not only inept, but also clearly has a malicious intent toward hospitalists.
- Dr. Peart complains incessantly about even tiny inequities in the work schedule or patient load. Others in the group have found that it is easier to ensure he always has the best schedule and lightest patient load, hoping they won’t have to hear his constant complaining. But even that hasn’t stemmed the steady downpour of negativity from him.
In all three of these cases, it seemed clear that the doctor should be terminated. And while the practice leadership agreed with me, they offered several excuses for why they hadn’t taken this step.
- “Who knows if we can find a replacement who will be any better?”
- “But he’s actually a decent doctor and doesn’t get a lot of complaints from patients.”
- “He’s such an angry guy, we worry about litigation if we fire him.”
I can’t offer any clear rule about when a practice should stop trying to improve a provider’s behavior and recognize that it is time to terminate the provider. But it is worth remembering that waiting too long has many costs, including the satisfaction of others in the group. Everyone will think less of the practice they are part of if poor behavior is tolerated.
Assess the Situation, Then Take Action
Most doctors who serve as the lead physician for their group have little or no experience dealing with problem behavior, let alone experience ensuring that necessary steps are followed prior to disciplining or terminating someone. But every hospital has someone who is very knowledgeable about these things; they should be engaged for advice, and, in the case of hospital-employed groups, should participate in the process of counseling and/or termination. It is important to take advantage of the expertise that is available.
Of course, the best approach is to prevent such problems from coming up. The best way to do this is to be very careful when hiring new providers. Checking references carefully is probably the best way to get an idea about whether someone might have behavior or personality problems. There are “job fit” survey instruments that you can use, but I’m not sure how effective they are, or how much value they add for a hospitalist practice beyond other means of assessing the candidate. And in the process of hiring someone, be sure to set behavior expectations very clearly. A new candidate should know that you will not tolerate not living up to behavioral expectations.
When dealing with bad behavior, make sure that you follow a careful and well-documented process. If someone still makes it through the hiring process only to be revealed as a troublemaker soon after their start date, don’t wait to sit that person down for very clear counseling; insist that their behavior change. Take notes of each meeting, and consider having the problem doctor sign and date the notes. While it might be easier to just wait and see if the first instance of bad behavior was an anomaly, that usually is a bad idea.
You should consider bringing the problem provider into the tent. The root of some bad behavior (i.e. criticism of leadership) is a person’s insecurity and lack of a feeling of ownership or control of their role in the practice. In that case, it might be reasonable to invite such a person into a role of greater responsibility in the practice so that they feel more in control. For example, a doctor who constantly complains about the work schedule might be invited to join the group’s executive committee or take on some other formal leadership role in the practice. This could backfire, so it should be tried only in carefully selected cases, and with the problem doctor’s clear understanding that they are being given a chance to have a bigger role in the practice but must improve their behavior or face serious consequences that could include termination.
I have seen this work beautifully in some cases, curing the problem behavior and turning the doctor into a valuable asset. I only wish there were a reliable way to know when to try this strategy. Sadly, it just requires judgment and intuition. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.
The providers in every hospitalist practice should be a good fit for the practice’s culture. They should have reasonable relationships with their colleagues in the practice, patients and families, and other staff at the hospital.
I can’t imagine anyone arguing with this point of view. But in my work with hundreds of hospitalist practices over the past 15 years, I’ve found that many practices seem to have a hard time ensuring their providers meet that standard. I can think of lots of reasons for this. The first that comes to mind is the difficult HM recruiting environment. Almost all hospitalist practices needed to grow quickly, and many lowered the bar in the qualifications and the fit of the candidates they hired to make sure they filled all of their positions.
Even if it later becomes clear a provider isn’t a good fit for the group culture, or worse still lacks the knowledge base and judgment to perform well, many practices are reluctant to replace the hospitalist because it might be difficult to find a replacement—and there is no guarantee the new person will perform any better. Because of this, a number of practices have ended up with providers who in many cases have a negative influence on others in the practice, and both the practice and the problem provider would be better off if the provider went elsewhere.
The Problem Physician
To their credit, most practices do act when a provider simply lacks the skill and judgment to perform adequately. This can mean close proctoring/mentoring for an extended period, or requiring specific CME course work to correct a skill that is lacking. But it also means reassigning the person to a different job, or termination.
But in the case of someone with a toxic personality, practices often are more reluctant to act. I’ll often hear the leadership of a practice say something like, “We knew Alice wasn’t a good fit for our practice within a few weeks of her start date.” The start date was several years ago and nothing has been done about this. Not surprisingly, Alice still performs poorly.
I’m not talking about someone who has occasional problems. I’m talking about people who cause problems almost every time they show up to work. Here are some real anecdotes, with fictitious names to ensure anonymity for the person and institution:
- Dr. Lee routinely disappears for several hours, during which he doesn’t answer pages. This even happens when he is the only doctor covering the practice.
- Dr. Lifeson, while generally getting along well with his fellow hospitalists and the nursing staff, can be counted on to complain bitterly about all levels of the hospital administration and leadership. He never misses an opportunity to try to convince other hospitalists that the leadership is not only inept, but also clearly has a malicious intent toward hospitalists.
- Dr. Peart complains incessantly about even tiny inequities in the work schedule or patient load. Others in the group have found that it is easier to ensure he always has the best schedule and lightest patient load, hoping they won’t have to hear his constant complaining. But even that hasn’t stemmed the steady downpour of negativity from him.
In all three of these cases, it seemed clear that the doctor should be terminated. And while the practice leadership agreed with me, they offered several excuses for why they hadn’t taken this step.
- “Who knows if we can find a replacement who will be any better?”
- “But he’s actually a decent doctor and doesn’t get a lot of complaints from patients.”
- “He’s such an angry guy, we worry about litigation if we fire him.”
I can’t offer any clear rule about when a practice should stop trying to improve a provider’s behavior and recognize that it is time to terminate the provider. But it is worth remembering that waiting too long has many costs, including the satisfaction of others in the group. Everyone will think less of the practice they are part of if poor behavior is tolerated.
Assess the Situation, Then Take Action
Most doctors who serve as the lead physician for their group have little or no experience dealing with problem behavior, let alone experience ensuring that necessary steps are followed prior to disciplining or terminating someone. But every hospital has someone who is very knowledgeable about these things; they should be engaged for advice, and, in the case of hospital-employed groups, should participate in the process of counseling and/or termination. It is important to take advantage of the expertise that is available.
Of course, the best approach is to prevent such problems from coming up. The best way to do this is to be very careful when hiring new providers. Checking references carefully is probably the best way to get an idea about whether someone might have behavior or personality problems. There are “job fit” survey instruments that you can use, but I’m not sure how effective they are, or how much value they add for a hospitalist practice beyond other means of assessing the candidate. And in the process of hiring someone, be sure to set behavior expectations very clearly. A new candidate should know that you will not tolerate not living up to behavioral expectations.
When dealing with bad behavior, make sure that you follow a careful and well-documented process. If someone still makes it through the hiring process only to be revealed as a troublemaker soon after their start date, don’t wait to sit that person down for very clear counseling; insist that their behavior change. Take notes of each meeting, and consider having the problem doctor sign and date the notes. While it might be easier to just wait and see if the first instance of bad behavior was an anomaly, that usually is a bad idea.
You should consider bringing the problem provider into the tent. The root of some bad behavior (i.e. criticism of leadership) is a person’s insecurity and lack of a feeling of ownership or control of their role in the practice. In that case, it might be reasonable to invite such a person into a role of greater responsibility in the practice so that they feel more in control. For example, a doctor who constantly complains about the work schedule might be invited to join the group’s executive committee or take on some other formal leadership role in the practice. This could backfire, so it should be tried only in carefully selected cases, and with the problem doctor’s clear understanding that they are being given a chance to have a bigger role in the practice but must improve their behavior or face serious consequences that could include termination.
I have seen this work beautifully in some cases, curing the problem behavior and turning the doctor into a valuable asset. I only wish there were a reliable way to know when to try this strategy. Sadly, it just requires judgment and intuition. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.
Just how much does screening mammography reduce mortality from breast cancer?
In its 2009 assessment of the benefits of screening mammography among women 50 to 69 years old, the US Preventive Services Task Force (USPSTF) estimated that the modality reduces mortality from breast cancer by 14% to 32%. However, that estimate is based on studies conducted more than 20 years ago.1
In 1996, some parts of Norway began to offer screening mammography. By 2005, screening had become universally available in the country, with more than 75% of the eligible population participating. During that decade, Norway also established multidisciplinary teams to improve the management of women given a diagnosis of breast cancer.
To determine the effects of modern screening, investigators in Norway compared breast cancer mortality in four groups:
- women who lived, from 1996 through 2005, in counties in that country that offered mammography screening
- those who lived, from 1986 through 1995, in these same counties
- those who lived, from 1996 through 2005, in counties that did not offer screening
- those who lived, from 1986 through 1995, in these same counties.
The impact of the combination of mammography screening and multidisciplinary management of breast cancer cases was a 10% reduction in breast cancer mortality. Women who did not undergo mammography screening but whose cancers were treated according to the new paradigm experienced an 8% reduction in breast cancer mortality. That suggests that the reduction in mortality that can be attributed solely to screening mammography is a surprisingly low 2%. In other words, mammography may prevent as few as 2.4 deaths for every 100,000 person-years.
Although these numbers may appear to be strikingly low, the authors point out that they are consistent with those from Britain’s national screening program.
Can the low figures be good news?
Although some practitioners may view these data with confusion or even hostility, I see the findings of this study as good news: We have improved our treatment of breast cancer so dramatically over the past few decades that the benefits of early diagnosis have become attenuated. As an editorial accompanying the Norwegian study postulates, “It is quite plausible that screening mammography was more effective in the past than it is now. If women with new breast lumps now present earlier for evaluation, the benefit of screening will be less. If treatment of clinically detected breast cancer (i.e., tumors that are detected by means other than screening) has now improved, the benefit of screening will be less. Thus, the increased awareness about the importance of promptly seeking care for overt breast abnormalities (there is no debate about diagnostic mammography) and the widespread use of adjuvant therapy may have combined to make screening now less important.”2
What about women under 50?
Breast cancer is uncommon in women in their 40s, and screening mammograms are associated with a high rate of false-positive results and unnecessary additional imaging and biopsies in this age group. In late 2009, these observations led the USPSTF to recommend against routinely screening women 40 to 49 years old.3
Now, a study from Sweden provides data that contradict that position.4 In Sweden, a screening-mammography program was initiated for women 40 to 74 years old between 1986 and 1997. In 1987 and 1988, national guidelines were revised to allow counties that faced financial challenges to curtail screening for women younger than 50 years. At that time, about 50% of Swedish counties discontinued screening of younger women. The remaining counties continued screening women in their 40s at intervals ranging from 18 to 24 months.
From 1986 through 2005, 803 women died from breast cancer that was diagnosed when they were 40 to 49 years old and who were screened by mammography (7.3 million person-years). During the same period, 1,238 women died from breast cancer that was diagnosed when they were 40 to 49 years old and who were not screened by mammography (8.8 million person-years).
Investigators calculated the odds ratio (OR) for fatal breast cancer among women who were screened in their 40s: 0.71 (95% confidence interval [CI], 0.62–0.80). They also estimated that, over a 10-year period (roughly six screening mammograms), one case of fatal breast cancer was prevented among every 1,252 women screened.
Picture remains a bit murky
Coming less than a year after the aforementioned USPSTF recommendations against screening women under 50, and right on the heels of the Norwegian study minimizing the value of screening in women 50 to 69 years old, these new data have ignited controversy.
Unlike their Norwegian counterparts, Swedish investigators failed to report mortality rates, making interpretation of the data difficult. Nor did they detail the health costs of mammograms among women in their 40s.
Note: For more on the debate over screening mammography, see Dr. Kaunitz’s earlier commentary on the subject, “I’ve been rethinking my zeal for breast cancer screening,” in the December 2009 issue of OBG Management, and Dr. Robert L. Barbieri’s distinctive viewpoint, “Access to screening mammography: Priceless,” in the January 2010 issue at obgmanagement.com.
For the foreseeable future, most clinicians will continue to recommend regular screening for women 50 to 69 years old, and most women will continue to choose to have mammograms. In my practice, however, I plan to spend less time nagging women who are reluctant to get mammograms. I now feel more comfortable recommending screening consistent with the US Preventive Services Task Force guidelines from late 2009.
As for women 40 to 49 years old, I plan to continue following USPSTF guidelines. However, I will also continue to order screens for women in their 40s who are at increased risk of breast cancer due to family history or other reasons and for those who prefer to be screened despite awareness of the high rate of false-positive findings.
—ANDREW M. KAUNITZ, MD
We want to hear from you! Tell us what you think.
1. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-737.
2. Welch HG. Screening mammography—a long run for a short slide? N Engl J Med. 2010;363(13):1276-1278.
3. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726.
4. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40–49 years: evaluation of the Swedish Mammography Screening in young women (SCRY) cohort [published online ahead of print September 29, 2010]. Cancer. doi:10.1002/cncr.25650.
In its 2009 assessment of the benefits of screening mammography among women 50 to 69 years old, the US Preventive Services Task Force (USPSTF) estimated that the modality reduces mortality from breast cancer by 14% to 32%. However, that estimate is based on studies conducted more than 20 years ago.1
In 1996, some parts of Norway began to offer screening mammography. By 2005, screening had become universally available in the country, with more than 75% of the eligible population participating. During that decade, Norway also established multidisciplinary teams to improve the management of women given a diagnosis of breast cancer.
To determine the effects of modern screening, investigators in Norway compared breast cancer mortality in four groups:
- women who lived, from 1996 through 2005, in counties in that country that offered mammography screening
- those who lived, from 1986 through 1995, in these same counties
- those who lived, from 1996 through 2005, in counties that did not offer screening
- those who lived, from 1986 through 1995, in these same counties.
The impact of the combination of mammography screening and multidisciplinary management of breast cancer cases was a 10% reduction in breast cancer mortality. Women who did not undergo mammography screening but whose cancers were treated according to the new paradigm experienced an 8% reduction in breast cancer mortality. That suggests that the reduction in mortality that can be attributed solely to screening mammography is a surprisingly low 2%. In other words, mammography may prevent as few as 2.4 deaths for every 100,000 person-years.
Although these numbers may appear to be strikingly low, the authors point out that they are consistent with those from Britain’s national screening program.
Can the low figures be good news?
Although some practitioners may view these data with confusion or even hostility, I see the findings of this study as good news: We have improved our treatment of breast cancer so dramatically over the past few decades that the benefits of early diagnosis have become attenuated. As an editorial accompanying the Norwegian study postulates, “It is quite plausible that screening mammography was more effective in the past than it is now. If women with new breast lumps now present earlier for evaluation, the benefit of screening will be less. If treatment of clinically detected breast cancer (i.e., tumors that are detected by means other than screening) has now improved, the benefit of screening will be less. Thus, the increased awareness about the importance of promptly seeking care for overt breast abnormalities (there is no debate about diagnostic mammography) and the widespread use of adjuvant therapy may have combined to make screening now less important.”2
What about women under 50?
Breast cancer is uncommon in women in their 40s, and screening mammograms are associated with a high rate of false-positive results and unnecessary additional imaging and biopsies in this age group. In late 2009, these observations led the USPSTF to recommend against routinely screening women 40 to 49 years old.3
Now, a study from Sweden provides data that contradict that position.4 In Sweden, a screening-mammography program was initiated for women 40 to 74 years old between 1986 and 1997. In 1987 and 1988, national guidelines were revised to allow counties that faced financial challenges to curtail screening for women younger than 50 years. At that time, about 50% of Swedish counties discontinued screening of younger women. The remaining counties continued screening women in their 40s at intervals ranging from 18 to 24 months.
From 1986 through 2005, 803 women died from breast cancer that was diagnosed when they were 40 to 49 years old and who were screened by mammography (7.3 million person-years). During the same period, 1,238 women died from breast cancer that was diagnosed when they were 40 to 49 years old and who were not screened by mammography (8.8 million person-years).
Investigators calculated the odds ratio (OR) for fatal breast cancer among women who were screened in their 40s: 0.71 (95% confidence interval [CI], 0.62–0.80). They also estimated that, over a 10-year period (roughly six screening mammograms), one case of fatal breast cancer was prevented among every 1,252 women screened.
Picture remains a bit murky
Coming less than a year after the aforementioned USPSTF recommendations against screening women under 50, and right on the heels of the Norwegian study minimizing the value of screening in women 50 to 69 years old, these new data have ignited controversy.
Unlike their Norwegian counterparts, Swedish investigators failed to report mortality rates, making interpretation of the data difficult. Nor did they detail the health costs of mammograms among women in their 40s.
Note: For more on the debate over screening mammography, see Dr. Kaunitz’s earlier commentary on the subject, “I’ve been rethinking my zeal for breast cancer screening,” in the December 2009 issue of OBG Management, and Dr. Robert L. Barbieri’s distinctive viewpoint, “Access to screening mammography: Priceless,” in the January 2010 issue at obgmanagement.com.
For the foreseeable future, most clinicians will continue to recommend regular screening for women 50 to 69 years old, and most women will continue to choose to have mammograms. In my practice, however, I plan to spend less time nagging women who are reluctant to get mammograms. I now feel more comfortable recommending screening consistent with the US Preventive Services Task Force guidelines from late 2009.
As for women 40 to 49 years old, I plan to continue following USPSTF guidelines. However, I will also continue to order screens for women in their 40s who are at increased risk of breast cancer due to family history or other reasons and for those who prefer to be screened despite awareness of the high rate of false-positive findings.
—ANDREW M. KAUNITZ, MD
We want to hear from you! Tell us what you think.
In its 2009 assessment of the benefits of screening mammography among women 50 to 69 years old, the US Preventive Services Task Force (USPSTF) estimated that the modality reduces mortality from breast cancer by 14% to 32%. However, that estimate is based on studies conducted more than 20 years ago.1
In 1996, some parts of Norway began to offer screening mammography. By 2005, screening had become universally available in the country, with more than 75% of the eligible population participating. During that decade, Norway also established multidisciplinary teams to improve the management of women given a diagnosis of breast cancer.
To determine the effects of modern screening, investigators in Norway compared breast cancer mortality in four groups:
- women who lived, from 1996 through 2005, in counties in that country that offered mammography screening
- those who lived, from 1986 through 1995, in these same counties
- those who lived, from 1996 through 2005, in counties that did not offer screening
- those who lived, from 1986 through 1995, in these same counties.
The impact of the combination of mammography screening and multidisciplinary management of breast cancer cases was a 10% reduction in breast cancer mortality. Women who did not undergo mammography screening but whose cancers were treated according to the new paradigm experienced an 8% reduction in breast cancer mortality. That suggests that the reduction in mortality that can be attributed solely to screening mammography is a surprisingly low 2%. In other words, mammography may prevent as few as 2.4 deaths for every 100,000 person-years.
Although these numbers may appear to be strikingly low, the authors point out that they are consistent with those from Britain’s national screening program.
Can the low figures be good news?
Although some practitioners may view these data with confusion or even hostility, I see the findings of this study as good news: We have improved our treatment of breast cancer so dramatically over the past few decades that the benefits of early diagnosis have become attenuated. As an editorial accompanying the Norwegian study postulates, “It is quite plausible that screening mammography was more effective in the past than it is now. If women with new breast lumps now present earlier for evaluation, the benefit of screening will be less. If treatment of clinically detected breast cancer (i.e., tumors that are detected by means other than screening) has now improved, the benefit of screening will be less. Thus, the increased awareness about the importance of promptly seeking care for overt breast abnormalities (there is no debate about diagnostic mammography) and the widespread use of adjuvant therapy may have combined to make screening now less important.”2
What about women under 50?
Breast cancer is uncommon in women in their 40s, and screening mammograms are associated with a high rate of false-positive results and unnecessary additional imaging and biopsies in this age group. In late 2009, these observations led the USPSTF to recommend against routinely screening women 40 to 49 years old.3
Now, a study from Sweden provides data that contradict that position.4 In Sweden, a screening-mammography program was initiated for women 40 to 74 years old between 1986 and 1997. In 1987 and 1988, national guidelines were revised to allow counties that faced financial challenges to curtail screening for women younger than 50 years. At that time, about 50% of Swedish counties discontinued screening of younger women. The remaining counties continued screening women in their 40s at intervals ranging from 18 to 24 months.
From 1986 through 2005, 803 women died from breast cancer that was diagnosed when they were 40 to 49 years old and who were screened by mammography (7.3 million person-years). During the same period, 1,238 women died from breast cancer that was diagnosed when they were 40 to 49 years old and who were not screened by mammography (8.8 million person-years).
Investigators calculated the odds ratio (OR) for fatal breast cancer among women who were screened in their 40s: 0.71 (95% confidence interval [CI], 0.62–0.80). They also estimated that, over a 10-year period (roughly six screening mammograms), one case of fatal breast cancer was prevented among every 1,252 women screened.
Picture remains a bit murky
Coming less than a year after the aforementioned USPSTF recommendations against screening women under 50, and right on the heels of the Norwegian study minimizing the value of screening in women 50 to 69 years old, these new data have ignited controversy.
Unlike their Norwegian counterparts, Swedish investigators failed to report mortality rates, making interpretation of the data difficult. Nor did they detail the health costs of mammograms among women in their 40s.
Note: For more on the debate over screening mammography, see Dr. Kaunitz’s earlier commentary on the subject, “I’ve been rethinking my zeal for breast cancer screening,” in the December 2009 issue of OBG Management, and Dr. Robert L. Barbieri’s distinctive viewpoint, “Access to screening mammography: Priceless,” in the January 2010 issue at obgmanagement.com.
For the foreseeable future, most clinicians will continue to recommend regular screening for women 50 to 69 years old, and most women will continue to choose to have mammograms. In my practice, however, I plan to spend less time nagging women who are reluctant to get mammograms. I now feel more comfortable recommending screening consistent with the US Preventive Services Task Force guidelines from late 2009.
As for women 40 to 49 years old, I plan to continue following USPSTF guidelines. However, I will also continue to order screens for women in their 40s who are at increased risk of breast cancer due to family history or other reasons and for those who prefer to be screened despite awareness of the high rate of false-positive findings.
—ANDREW M. KAUNITZ, MD
We want to hear from you! Tell us what you think.
1. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-737.
2. Welch HG. Screening mammography—a long run for a short slide? N Engl J Med. 2010;363(13):1276-1278.
3. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726.
4. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40–49 years: evaluation of the Swedish Mammography Screening in young women (SCRY) cohort [published online ahead of print September 29, 2010]. Cancer. doi:10.1002/cncr.25650.
1. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-737.
2. Welch HG. Screening mammography—a long run for a short slide? N Engl J Med. 2010;363(13):1276-1278.
3. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726.
4. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40–49 years: evaluation of the Swedish Mammography Screening in young women (SCRY) cohort [published online ahead of print September 29, 2010]. Cancer. doi:10.1002/cncr.25650.
Volume Control, Part II
Last month I began looking at ways hospitalist practices can manage unpredictable increases in patient volume, also known as surge staffing. I provided my view of a “jeopardy” system and a patient volume cap for hospitalists. While both are potentially very effective, they have a high cost and in my view are imperfect solutions. This month I’ll examine some less common strategies to provide surge staffing. Although less popular, I think these options are more valuable.
Schedule More Providers
I’ve worked with a lot of practices and am struck by how patient volume for nearly all of them falls within a reasonably predictable range. While no one can predict with certainty which days will be unusually busy or slow, nearly all practices have a range of daily encounters that is roughly half to 1 1/2 of the mean. For example, if a practice has a mean of 60 billable encounters per day, it probably ranges from about 30 to 90 encounters on any given day. (The larger the practice, the more likely they are to conform to this range. Small practices, with average daily encounters fewer than 20, have a much wider range of daily volumes as a percent of the mean.)
Despite knowing that volumes will vary unpredictably, most practices provide the same fixed “dose” of provider staffing every day—that is, the single most common model for staffing and scheduling is to provide a fixed number of day-shift doctors (“rounders”) who work a fixed number of hours. For example, with an average of 60 billable encounters a day, a hospitalist group might decide to staff with four day-shift rounders working 12-hour shifts. This equates to a fixed 48 hours of daytime staffing. This is reasonable until the busy days arrive. Those four doctors will be much busier than average when there are 90 patients to see in a day, and will probably have a hard time seeing 22 or 23 patients each during their 12-hour shift. If such a busy day occurs more than a couple of times annually, then the practice should probably make some changes.
One approach to solving this type of staffing predicament is to add a fifth day-shift rounder. In other words, when making staffing decisions, consider giving more weight to the busiest days than the average day. This sounds fine until thinking about the practice budget. It will be pretty expensive to add doctors every day just so there are enough on duty when things get really busy. But if the hospitalists are willing to accept reduced compensation, then it might be financially reasonable to go ahead and add staff. This is easiest to do when the hospitalists are paid a significant (e.g. ≥50%) portion of their income based on their productivity, which will enable the hospitalists themselves to have a lot of say about when it is time to add staff. (Being paid on a nearly fixed annual salary means that it is the finance person who usually has the say about when it is time to add staff. And you can bet he’ll be making staffing decisions based on the average daily encounters, rather than the busy days.)
My own preference would be to do just that: Accept a reduction in compensation in return for protection against really busy and stressful days. I’m not suggesting others should agree with me, and in my experience, most don’t. (My own practice partners don’t agree with me on this one.) So I’m not really recommending it as a best practice, but I want to ensure that you don’t forget it is an option. And keep in mind you could adjust staffing by degrees; some settings might add a half-time physician or a nonphysician provider to try to find the sweet spot between having enough staff on duty every day to handle surges in volume and the cost of that staffing to the employer—or the hospitalists themselves.
Of course, if I were willing to reduce my compensation and average daily workload, then I would expect to be freed from the expectation that all rounding doctors work 12-hour shifts. Let’s turn our attention to the interplay between fixed day-shift durations and surge staffing.
Fixed-Shift Schedules Inhibit Surge Capacity
I think it usually is best to avoid fixed durations for day shifts. It might be necessary to require at least one daytime rounder to stay at least until a specified time (e.g. the arrival of the night-shift doctor), but in most cases it is reasonable for some rounders to leave when their work is done. They might need to continue responding to pages until the start of the night shift, but it usually isn’t necessary to have all rounders in the hospital until a predetermined end of the shift.
The problem is that when shifts have a fixed duration, the providers will focus on the start and stop time of their shift and might be unwilling to work beyond it. If instead there are no clearly fixed start and stop times for each day shift, then the hospitalists are likely to be willing to simply work longer on busy days, as long as they can work shorter on slow days. This is probably the most effective method of surge capacity, and it fits well with staffing each day with more providers than are required for the average patient volume.
Simply having the rounding doctors work longer on busy days must be done within reason. And there is a really wide range of opinion about what is reasonable. I think it is reasonable if a hospitalist works two or three hours longer than usual for three or four consecutive busy days, as long as the hospitalist is allowed to work less on days that are not very busy. But just what is a reasonable maximum daily amount of work for even one day is a topic that can lead to passionate debate. You’ll have to decide the details of what is and isn’t acceptable in your group.
Unit-Based Assignments
Aside from fixed-duration day shifts, unit-based assignment of hospitalists is the most common practice inhibiting surge capacity. Not long ago I worked with a practice that followed very strict unit-based assignments, which significantly inhibited “load-leveling,” and thus surge capacity. On any given day the patient volume for the whole practice might be very reasonable, but because it was never distributed evenly among the rounders, there was a very good chance that at least one doctor was drowning in work. And because of the strict approach, the other doctors didn’t come to the rescue.
I think the only reasonable approach is to deviate from such a strict unit-based assignment, at least a little. One rounder could be a utility doctor who doesn’t have her own unit and instead roams throughout the hospital, having been assigned patients based on the workload of each of her unit-based colleagues. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is cofounder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants (www.nelsonflores.com) and codirector and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.
Last month I began looking at ways hospitalist practices can manage unpredictable increases in patient volume, also known as surge staffing. I provided my view of a “jeopardy” system and a patient volume cap for hospitalists. While both are potentially very effective, they have a high cost and in my view are imperfect solutions. This month I’ll examine some less common strategies to provide surge staffing. Although less popular, I think these options are more valuable.
Schedule More Providers
I’ve worked with a lot of practices and am struck by how patient volume for nearly all of them falls within a reasonably predictable range. While no one can predict with certainty which days will be unusually busy or slow, nearly all practices have a range of daily encounters that is roughly half to 1 1/2 of the mean. For example, if a practice has a mean of 60 billable encounters per day, it probably ranges from about 30 to 90 encounters on any given day. (The larger the practice, the more likely they are to conform to this range. Small practices, with average daily encounters fewer than 20, have a much wider range of daily volumes as a percent of the mean.)
Despite knowing that volumes will vary unpredictably, most practices provide the same fixed “dose” of provider staffing every day—that is, the single most common model for staffing and scheduling is to provide a fixed number of day-shift doctors (“rounders”) who work a fixed number of hours. For example, with an average of 60 billable encounters a day, a hospitalist group might decide to staff with four day-shift rounders working 12-hour shifts. This equates to a fixed 48 hours of daytime staffing. This is reasonable until the busy days arrive. Those four doctors will be much busier than average when there are 90 patients to see in a day, and will probably have a hard time seeing 22 or 23 patients each during their 12-hour shift. If such a busy day occurs more than a couple of times annually, then the practice should probably make some changes.
One approach to solving this type of staffing predicament is to add a fifth day-shift rounder. In other words, when making staffing decisions, consider giving more weight to the busiest days than the average day. This sounds fine until thinking about the practice budget. It will be pretty expensive to add doctors every day just so there are enough on duty when things get really busy. But if the hospitalists are willing to accept reduced compensation, then it might be financially reasonable to go ahead and add staff. This is easiest to do when the hospitalists are paid a significant (e.g. ≥50%) portion of their income based on their productivity, which will enable the hospitalists themselves to have a lot of say about when it is time to add staff. (Being paid on a nearly fixed annual salary means that it is the finance person who usually has the say about when it is time to add staff. And you can bet he’ll be making staffing decisions based on the average daily encounters, rather than the busy days.)
My own preference would be to do just that: Accept a reduction in compensation in return for protection against really busy and stressful days. I’m not suggesting others should agree with me, and in my experience, most don’t. (My own practice partners don’t agree with me on this one.) So I’m not really recommending it as a best practice, but I want to ensure that you don’t forget it is an option. And keep in mind you could adjust staffing by degrees; some settings might add a half-time physician or a nonphysician provider to try to find the sweet spot between having enough staff on duty every day to handle surges in volume and the cost of that staffing to the employer—or the hospitalists themselves.
Of course, if I were willing to reduce my compensation and average daily workload, then I would expect to be freed from the expectation that all rounding doctors work 12-hour shifts. Let’s turn our attention to the interplay between fixed day-shift durations and surge staffing.
Fixed-Shift Schedules Inhibit Surge Capacity
I think it usually is best to avoid fixed durations for day shifts. It might be necessary to require at least one daytime rounder to stay at least until a specified time (e.g. the arrival of the night-shift doctor), but in most cases it is reasonable for some rounders to leave when their work is done. They might need to continue responding to pages until the start of the night shift, but it usually isn’t necessary to have all rounders in the hospital until a predetermined end of the shift.
The problem is that when shifts have a fixed duration, the providers will focus on the start and stop time of their shift and might be unwilling to work beyond it. If instead there are no clearly fixed start and stop times for each day shift, then the hospitalists are likely to be willing to simply work longer on busy days, as long as they can work shorter on slow days. This is probably the most effective method of surge capacity, and it fits well with staffing each day with more providers than are required for the average patient volume.
Simply having the rounding doctors work longer on busy days must be done within reason. And there is a really wide range of opinion about what is reasonable. I think it is reasonable if a hospitalist works two or three hours longer than usual for three or four consecutive busy days, as long as the hospitalist is allowed to work less on days that are not very busy. But just what is a reasonable maximum daily amount of work for even one day is a topic that can lead to passionate debate. You’ll have to decide the details of what is and isn’t acceptable in your group.
Unit-Based Assignments
Aside from fixed-duration day shifts, unit-based assignment of hospitalists is the most common practice inhibiting surge capacity. Not long ago I worked with a practice that followed very strict unit-based assignments, which significantly inhibited “load-leveling,” and thus surge capacity. On any given day the patient volume for the whole practice might be very reasonable, but because it was never distributed evenly among the rounders, there was a very good chance that at least one doctor was drowning in work. And because of the strict approach, the other doctors didn’t come to the rescue.
I think the only reasonable approach is to deviate from such a strict unit-based assignment, at least a little. One rounder could be a utility doctor who doesn’t have her own unit and instead roams throughout the hospital, having been assigned patients based on the workload of each of her unit-based colleagues. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is cofounder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants (www.nelsonflores.com) and codirector and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.
Last month I began looking at ways hospitalist practices can manage unpredictable increases in patient volume, also known as surge staffing. I provided my view of a “jeopardy” system and a patient volume cap for hospitalists. While both are potentially very effective, they have a high cost and in my view are imperfect solutions. This month I’ll examine some less common strategies to provide surge staffing. Although less popular, I think these options are more valuable.
Schedule More Providers
I’ve worked with a lot of practices and am struck by how patient volume for nearly all of them falls within a reasonably predictable range. While no one can predict with certainty which days will be unusually busy or slow, nearly all practices have a range of daily encounters that is roughly half to 1 1/2 of the mean. For example, if a practice has a mean of 60 billable encounters per day, it probably ranges from about 30 to 90 encounters on any given day. (The larger the practice, the more likely they are to conform to this range. Small practices, with average daily encounters fewer than 20, have a much wider range of daily volumes as a percent of the mean.)
Despite knowing that volumes will vary unpredictably, most practices provide the same fixed “dose” of provider staffing every day—that is, the single most common model for staffing and scheduling is to provide a fixed number of day-shift doctors (“rounders”) who work a fixed number of hours. For example, with an average of 60 billable encounters a day, a hospitalist group might decide to staff with four day-shift rounders working 12-hour shifts. This equates to a fixed 48 hours of daytime staffing. This is reasonable until the busy days arrive. Those four doctors will be much busier than average when there are 90 patients to see in a day, and will probably have a hard time seeing 22 or 23 patients each during their 12-hour shift. If such a busy day occurs more than a couple of times annually, then the practice should probably make some changes.
One approach to solving this type of staffing predicament is to add a fifth day-shift rounder. In other words, when making staffing decisions, consider giving more weight to the busiest days than the average day. This sounds fine until thinking about the practice budget. It will be pretty expensive to add doctors every day just so there are enough on duty when things get really busy. But if the hospitalists are willing to accept reduced compensation, then it might be financially reasonable to go ahead and add staff. This is easiest to do when the hospitalists are paid a significant (e.g. ≥50%) portion of their income based on their productivity, which will enable the hospitalists themselves to have a lot of say about when it is time to add staff. (Being paid on a nearly fixed annual salary means that it is the finance person who usually has the say about when it is time to add staff. And you can bet he’ll be making staffing decisions based on the average daily encounters, rather than the busy days.)
My own preference would be to do just that: Accept a reduction in compensation in return for protection against really busy and stressful days. I’m not suggesting others should agree with me, and in my experience, most don’t. (My own practice partners don’t agree with me on this one.) So I’m not really recommending it as a best practice, but I want to ensure that you don’t forget it is an option. And keep in mind you could adjust staffing by degrees; some settings might add a half-time physician or a nonphysician provider to try to find the sweet spot between having enough staff on duty every day to handle surges in volume and the cost of that staffing to the employer—or the hospitalists themselves.
Of course, if I were willing to reduce my compensation and average daily workload, then I would expect to be freed from the expectation that all rounding doctors work 12-hour shifts. Let’s turn our attention to the interplay between fixed day-shift durations and surge staffing.
Fixed-Shift Schedules Inhibit Surge Capacity
I think it usually is best to avoid fixed durations for day shifts. It might be necessary to require at least one daytime rounder to stay at least until a specified time (e.g. the arrival of the night-shift doctor), but in most cases it is reasonable for some rounders to leave when their work is done. They might need to continue responding to pages until the start of the night shift, but it usually isn’t necessary to have all rounders in the hospital until a predetermined end of the shift.
The problem is that when shifts have a fixed duration, the providers will focus on the start and stop time of their shift and might be unwilling to work beyond it. If instead there are no clearly fixed start and stop times for each day shift, then the hospitalists are likely to be willing to simply work longer on busy days, as long as they can work shorter on slow days. This is probably the most effective method of surge capacity, and it fits well with staffing each day with more providers than are required for the average patient volume.
Simply having the rounding doctors work longer on busy days must be done within reason. And there is a really wide range of opinion about what is reasonable. I think it is reasonable if a hospitalist works two or three hours longer than usual for three or four consecutive busy days, as long as the hospitalist is allowed to work less on days that are not very busy. But just what is a reasonable maximum daily amount of work for even one day is a topic that can lead to passionate debate. You’ll have to decide the details of what is and isn’t acceptable in your group.
Unit-Based Assignments
Aside from fixed-duration day shifts, unit-based assignment of hospitalists is the most common practice inhibiting surge capacity. Not long ago I worked with a practice that followed very strict unit-based assignments, which significantly inhibited “load-leveling,” and thus surge capacity. On any given day the patient volume for the whole practice might be very reasonable, but because it was never distributed evenly among the rounders, there was a very good chance that at least one doctor was drowning in work. And because of the strict approach, the other doctors didn’t come to the rescue.
I think the only reasonable approach is to deviate from such a strict unit-based assignment, at least a little. One rounder could be a utility doctor who doesn’t have her own unit and instead roams throughout the hospital, having been assigned patients based on the workload of each of her unit-based colleagues. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is cofounder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants (www.nelsonflores.com) and codirector and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.
At what thickness is the endometrial stripe cause for concern in a woman who has postmenopausal bleeding?
Since transvaginal ultrasonography (TVS) was introduced in the 1980s, it has been increasingly utilized to evaluate postmenopausal vaginal bleeding. In August 2009, ACOG reissued a Committee Opinion on the use of TVS in this setting.1 Based on the very high negative predictive value of TVS, ACOG recommended a cutoff of 4 mm for endometrial thickness: That is, endometrial stripes 4 mm or thinner require no endometrial sampling; only those thicker than 4 mm require a biopsy.2
How can we interpret this study, which recommends changing that cutoff to 3 mm?
Meta-analysis focused on individual patient data
Timmermans and coworkers employed an unusual statistical approach in their meta-analysis: Rather than use entire datasets from each study included in their analysis, they attempted to obtain individual patient data. They identified 74 investigations that reported endometrial thickness and endometrial carcinoma rates in women who experienced postmenopausal bleeding. They obtained individual data from 13 of these studies, representing 2,896 women. Using a sophisticated receiver operator characteristic (ROC) curve analysis, they calculated summary estimates of the sensitivity and specificity of TVS in diagnosing endometrial cancer in this population. They found the diagnostic accuracy of TVS to be lower than the accuracy demonstrated in the most frequently cited meta-analysis in the literature.3
TVS accurately predicted the presence of endometrial cancer in women who had postmenopausal bleeding with different rates of sensitivity and specificity, depending on the cutoff used:
- 5 mm—sensitivity, 90.3% (95% confidence interval [CI], 80.0%–95.5%); specificity, 54% (95% CI, 46.7%–61.2%)
- 4 mm—sensitivity, 94.8% (95% CI, 86.1%–98.2%); specificity, 46.7% (95% CI, 38.3%–55.2%)
- 3 mm—sensitivity, 97.9% (95% CI, 90.1%–99.6%); specificity, 35.4% (95% CI, 29.3%–41.9%).
Sensitivity and specificity are integrally related; we increase sensitivity at the expense of specificity. Are we willing to increase our detection of true positive test results by also increasing the false-positive rate? The authors suggest that in the setting of a potential cancer diagnosis, clinicians should aim for 100% sensitivity—and they push for a 3-mm cutoff for that reason. However, if we shift to a 3-mm cutoff, considerably more women who do not have endometrial cancer will undergo biopsy. We must also be mindful of the false-negative rate of endometrial sampling and of the fact that not all women can be sampled, because of cervical stenosis or technical difficulties.
The preponderance of data supports the continued use of 4 mm as a cutoff for endometrial sampling: That is, only women who have postmenopausal bleeding and an endometrial stripe thicker than 4 mm need to undergo endometrial biopsy.
It is important to take other variables into account to improve our diagnostic accuracy without increasing the rate of unnecessary endometrial sampling. These variables include consideration of:
- the patient’s history and other characteristics5
- the persistence of postmenopausal bleeding4
- cervical cytology.6
—LINDA R. DUSKA, MD
Strengths and weaknesses of the study
One strength of this analysis is that the investigators used the exact endometrial thickness for each patient rather than pooled data. Because of this requirement, however, only 13 of 74 studies of endometrial thickness and the endometrial cancer rate were able to provide data. Had all 74 publications provided data, many more patients would have been represented in the meta-analysis. Instead, bias was introduced because the small subset of patients whose individual data was available may not represent the entire population. The 95% confidence intervals for sensitivity and specificity reflect the small sample size.
This study also has a number of minor limitations. For example, it fails to address the fact that not all TVS studies are optimal studies. It can be difficult to measure the endometrial stripe when fibroids are present, when the patient has a history of uterine surgery, or when she is obese. Uterine position also can affect imaging.
In addition, the technology of TVS has improved significantly over the past two decades, making comparison of older studies (as early as 1995) to more modern studies (as recent as 2008) difficult to justify.
Timmermans and colleagues fail to provide information on the adequacy of TVS in assessing the endometrial stripe. Nor do they provide details on the histologic type of cancer in women who had thin endometrial stripes. The latter data would have been interesting because patients who have rare “type 2” endometrial cancers are more likely to exhibit endometrial stripes thinner than 4 mm.4
UPDATE: ENDOMETRIAL CANCER
Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial malignancy?
By David G. Mutch, MD, and B. J. Rimel, MD
We want to hear from you! Tell us what you think.
1. ACOG Committee Opinion#440: The role of transvaginal ultrasound in the evaluation of postmenopausal bleeding. Obstet Gynecol. 2009;114(2 Pt 1):409-411.
2. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding—a Nordic multicenter study. Am J Obstet Gynecol. 1995;172(5):1488-1494.
3. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998;280(17):1510-1517.
4. Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider C. Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers. Gynecol Oncol. 2006;101(1):120-125.
5. Opmeer BC, van Doorn HC, Heintz APM, Burger CW, Bossuyt PNM, Mol BW. Improving the existing diagnostic strategy by accounting for characteristics of the women in the diagnostic workup for postmenopausal bleeding. BJOG. 2007;114(1):51-58.
6. Van Doom HC, Opmeer BC, Kooi GS, Ewing-Graham PC, Kruitwagen RF, Mol BW. Value of cervical cytology in diagnosing endometrial carcinoma in women with postmenopausal bleeding. Acta Cytol. 2009;53(3):277-282.
Since transvaginal ultrasonography (TVS) was introduced in the 1980s, it has been increasingly utilized to evaluate postmenopausal vaginal bleeding. In August 2009, ACOG reissued a Committee Opinion on the use of TVS in this setting.1 Based on the very high negative predictive value of TVS, ACOG recommended a cutoff of 4 mm for endometrial thickness: That is, endometrial stripes 4 mm or thinner require no endometrial sampling; only those thicker than 4 mm require a biopsy.2
How can we interpret this study, which recommends changing that cutoff to 3 mm?
Meta-analysis focused on individual patient data
Timmermans and coworkers employed an unusual statistical approach in their meta-analysis: Rather than use entire datasets from each study included in their analysis, they attempted to obtain individual patient data. They identified 74 investigations that reported endometrial thickness and endometrial carcinoma rates in women who experienced postmenopausal bleeding. They obtained individual data from 13 of these studies, representing 2,896 women. Using a sophisticated receiver operator characteristic (ROC) curve analysis, they calculated summary estimates of the sensitivity and specificity of TVS in diagnosing endometrial cancer in this population. They found the diagnostic accuracy of TVS to be lower than the accuracy demonstrated in the most frequently cited meta-analysis in the literature.3
TVS accurately predicted the presence of endometrial cancer in women who had postmenopausal bleeding with different rates of sensitivity and specificity, depending on the cutoff used:
- 5 mm—sensitivity, 90.3% (95% confidence interval [CI], 80.0%–95.5%); specificity, 54% (95% CI, 46.7%–61.2%)
- 4 mm—sensitivity, 94.8% (95% CI, 86.1%–98.2%); specificity, 46.7% (95% CI, 38.3%–55.2%)
- 3 mm—sensitivity, 97.9% (95% CI, 90.1%–99.6%); specificity, 35.4% (95% CI, 29.3%–41.9%).
Sensitivity and specificity are integrally related; we increase sensitivity at the expense of specificity. Are we willing to increase our detection of true positive test results by also increasing the false-positive rate? The authors suggest that in the setting of a potential cancer diagnosis, clinicians should aim for 100% sensitivity—and they push for a 3-mm cutoff for that reason. However, if we shift to a 3-mm cutoff, considerably more women who do not have endometrial cancer will undergo biopsy. We must also be mindful of the false-negative rate of endometrial sampling and of the fact that not all women can be sampled, because of cervical stenosis or technical difficulties.
The preponderance of data supports the continued use of 4 mm as a cutoff for endometrial sampling: That is, only women who have postmenopausal bleeding and an endometrial stripe thicker than 4 mm need to undergo endometrial biopsy.
It is important to take other variables into account to improve our diagnostic accuracy without increasing the rate of unnecessary endometrial sampling. These variables include consideration of:
- the patient’s history and other characteristics5
- the persistence of postmenopausal bleeding4
- cervical cytology.6
—LINDA R. DUSKA, MD
Strengths and weaknesses of the study
One strength of this analysis is that the investigators used the exact endometrial thickness for each patient rather than pooled data. Because of this requirement, however, only 13 of 74 studies of endometrial thickness and the endometrial cancer rate were able to provide data. Had all 74 publications provided data, many more patients would have been represented in the meta-analysis. Instead, bias was introduced because the small subset of patients whose individual data was available may not represent the entire population. The 95% confidence intervals for sensitivity and specificity reflect the small sample size.
This study also has a number of minor limitations. For example, it fails to address the fact that not all TVS studies are optimal studies. It can be difficult to measure the endometrial stripe when fibroids are present, when the patient has a history of uterine surgery, or when she is obese. Uterine position also can affect imaging.
In addition, the technology of TVS has improved significantly over the past two decades, making comparison of older studies (as early as 1995) to more modern studies (as recent as 2008) difficult to justify.
Timmermans and colleagues fail to provide information on the adequacy of TVS in assessing the endometrial stripe. Nor do they provide details on the histologic type of cancer in women who had thin endometrial stripes. The latter data would have been interesting because patients who have rare “type 2” endometrial cancers are more likely to exhibit endometrial stripes thinner than 4 mm.4
UPDATE: ENDOMETRIAL CANCER
Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial malignancy?
By David G. Mutch, MD, and B. J. Rimel, MD
We want to hear from you! Tell us what you think.
Since transvaginal ultrasonography (TVS) was introduced in the 1980s, it has been increasingly utilized to evaluate postmenopausal vaginal bleeding. In August 2009, ACOG reissued a Committee Opinion on the use of TVS in this setting.1 Based on the very high negative predictive value of TVS, ACOG recommended a cutoff of 4 mm for endometrial thickness: That is, endometrial stripes 4 mm or thinner require no endometrial sampling; only those thicker than 4 mm require a biopsy.2
How can we interpret this study, which recommends changing that cutoff to 3 mm?
Meta-analysis focused on individual patient data
Timmermans and coworkers employed an unusual statistical approach in their meta-analysis: Rather than use entire datasets from each study included in their analysis, they attempted to obtain individual patient data. They identified 74 investigations that reported endometrial thickness and endometrial carcinoma rates in women who experienced postmenopausal bleeding. They obtained individual data from 13 of these studies, representing 2,896 women. Using a sophisticated receiver operator characteristic (ROC) curve analysis, they calculated summary estimates of the sensitivity and specificity of TVS in diagnosing endometrial cancer in this population. They found the diagnostic accuracy of TVS to be lower than the accuracy demonstrated in the most frequently cited meta-analysis in the literature.3
TVS accurately predicted the presence of endometrial cancer in women who had postmenopausal bleeding with different rates of sensitivity and specificity, depending on the cutoff used:
- 5 mm—sensitivity, 90.3% (95% confidence interval [CI], 80.0%–95.5%); specificity, 54% (95% CI, 46.7%–61.2%)
- 4 mm—sensitivity, 94.8% (95% CI, 86.1%–98.2%); specificity, 46.7% (95% CI, 38.3%–55.2%)
- 3 mm—sensitivity, 97.9% (95% CI, 90.1%–99.6%); specificity, 35.4% (95% CI, 29.3%–41.9%).
Sensitivity and specificity are integrally related; we increase sensitivity at the expense of specificity. Are we willing to increase our detection of true positive test results by also increasing the false-positive rate? The authors suggest that in the setting of a potential cancer diagnosis, clinicians should aim for 100% sensitivity—and they push for a 3-mm cutoff for that reason. However, if we shift to a 3-mm cutoff, considerably more women who do not have endometrial cancer will undergo biopsy. We must also be mindful of the false-negative rate of endometrial sampling and of the fact that not all women can be sampled, because of cervical stenosis or technical difficulties.
The preponderance of data supports the continued use of 4 mm as a cutoff for endometrial sampling: That is, only women who have postmenopausal bleeding and an endometrial stripe thicker than 4 mm need to undergo endometrial biopsy.
It is important to take other variables into account to improve our diagnostic accuracy without increasing the rate of unnecessary endometrial sampling. These variables include consideration of:
- the patient’s history and other characteristics5
- the persistence of postmenopausal bleeding4
- cervical cytology.6
—LINDA R. DUSKA, MD
Strengths and weaknesses of the study
One strength of this analysis is that the investigators used the exact endometrial thickness for each patient rather than pooled data. Because of this requirement, however, only 13 of 74 studies of endometrial thickness and the endometrial cancer rate were able to provide data. Had all 74 publications provided data, many more patients would have been represented in the meta-analysis. Instead, bias was introduced because the small subset of patients whose individual data was available may not represent the entire population. The 95% confidence intervals for sensitivity and specificity reflect the small sample size.
This study also has a number of minor limitations. For example, it fails to address the fact that not all TVS studies are optimal studies. It can be difficult to measure the endometrial stripe when fibroids are present, when the patient has a history of uterine surgery, or when she is obese. Uterine position also can affect imaging.
In addition, the technology of TVS has improved significantly over the past two decades, making comparison of older studies (as early as 1995) to more modern studies (as recent as 2008) difficult to justify.
Timmermans and colleagues fail to provide information on the adequacy of TVS in assessing the endometrial stripe. Nor do they provide details on the histologic type of cancer in women who had thin endometrial stripes. The latter data would have been interesting because patients who have rare “type 2” endometrial cancers are more likely to exhibit endometrial stripes thinner than 4 mm.4
UPDATE: ENDOMETRIAL CANCER
Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial malignancy?
By David G. Mutch, MD, and B. J. Rimel, MD
We want to hear from you! Tell us what you think.
1. ACOG Committee Opinion#440: The role of transvaginal ultrasound in the evaluation of postmenopausal bleeding. Obstet Gynecol. 2009;114(2 Pt 1):409-411.
2. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding—a Nordic multicenter study. Am J Obstet Gynecol. 1995;172(5):1488-1494.
3. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998;280(17):1510-1517.
4. Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider C. Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers. Gynecol Oncol. 2006;101(1):120-125.
5. Opmeer BC, van Doorn HC, Heintz APM, Burger CW, Bossuyt PNM, Mol BW. Improving the existing diagnostic strategy by accounting for characteristics of the women in the diagnostic workup for postmenopausal bleeding. BJOG. 2007;114(1):51-58.
6. Van Doom HC, Opmeer BC, Kooi GS, Ewing-Graham PC, Kruitwagen RF, Mol BW. Value of cervical cytology in diagnosing endometrial carcinoma in women with postmenopausal bleeding. Acta Cytol. 2009;53(3):277-282.
1. ACOG Committee Opinion#440: The role of transvaginal ultrasound in the evaluation of postmenopausal bleeding. Obstet Gynecol. 2009;114(2 Pt 1):409-411.
2. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding—a Nordic multicenter study. Am J Obstet Gynecol. 1995;172(5):1488-1494.
3. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998;280(17):1510-1517.
4. Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider C. Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers. Gynecol Oncol. 2006;101(1):120-125.
5. Opmeer BC, van Doorn HC, Heintz APM, Burger CW, Bossuyt PNM, Mol BW. Improving the existing diagnostic strategy by accounting for characteristics of the women in the diagnostic workup for postmenopausal bleeding. BJOG. 2007;114(1):51-58.
6. Van Doom HC, Opmeer BC, Kooi GS, Ewing-Graham PC, Kruitwagen RF, Mol BW. Value of cervical cytology in diagnosing endometrial carcinoma in women with postmenopausal bleeding. Acta Cytol. 2009;53(3):277-282.
Surge Protection
Unpredictable workloads and frequent interruptions are the things I regard as the most stressful components of work as a hospitalist. Your list might be very different, but I bet unpredictable workloads ranks at least in the top five of every hospitalist’s list.
I’ve discussed interruptions previously (see “Really, It’s Switch-Tasking,” p. 68, November 2008; “Technological Advance or Workplace Setback?” p. 69, December 2008), but this month and next will turn to unpredictable workloads. In other words, what are the strategies available to a hospitalist practice to provide surge capacity in response to such unpredictable increases in patient volume as an uptick in census or daily admissions 50% to 100% above normal? I’ll leave to others the topic of how hospitals respond to such disasters as terrorist attacks, earthquakes, etc.
The Bottom Line
Sadly, there is no magic bullet for the “surge” problem, and no way to protect on-duty hospitalists from the need to work harder when it gets busy. But we needn’t feel too sorry for ourselves; doctors in most other specialties who practice in the hospital face the same problem and tend to rely heavily on simply working harder and longer when it is unusually busy. Sometimes they couple the “work harder” mantra with other strategies, such as calling another doctor in to help.
Hospitalists have a duty to ensure high patient volume doesn’t lead to deterioration in the quality of patient care, but occasionally working longer days than average probably poses a low risk, and might be less risky than the additional handoffs usually associated with having a doctor on “jeopardy” to be called in when it’s busy. Routinely or frequently working unreasonably long days is another story.
The trick for HM programs is to build some surge capacity into the routine daily staffing 1) without exceeding a reasonable budget, while 2) ensuring that the hospitalists don’t simply become accustomed to light workloads as the only reasonable norm, which could lead to them becoming unwilling to accept higher, but still reasonable, workloads when needed. (More on these issues later.) First, I’ll go through what I see as the pros and cons of several approaches to addressing surges in patient volume. All are in use with variable frequency around the country.
“Jeopardy” System
In its most common form, a jeopardy system has an unscheduled doctor each day who must remain available on short notice by pager. When patient volume surges, the unscheduled doctor is paged to come in and help. In most cases, this doctor focuses primarily—or exclusively—on admitting patients for a few hours. So it is most common for this doctor to be called in late in the afternoon or early in the evening. The jeopardy doctor usually turns over all admitted patients to another hospitalist in the group for all subsequent care. In addition to providing surge capacity, the jeopardy doctor almost always is used to cover unexpected absences of scheduled doctors, including illness-related absences.
Sometimes this doctor is paid extra for each day or week spent being “available” on jeopardy duty (not to be confused with jury duty, though it can be equally difficult to get exempted from). Then again, it is not uncommon to have jeopardy duty included in base compensation. However, once a jeopardy doctor is actually called in to work, most practices pay additional compensation, often based on an hourly rate that usually is higher than the average compensation generated per hour for nonjeopardy work.
There are a number of reasonable ways to compensate the jeopardy doctor. You probably can get some good ideas by talking with others in your hospital who function in a similar capacity, such as cath-lab technicians who get called in on nights and weekends.
No definitive data are available to show how common the jeopardy system is, but my experience is that 30% to 50% of HM groups use some form of it. Its popularity is proof that it is a reasonable system, but I’m not convinced. I think it is in use by a lot of groups not because it is an optimal way to ensure surge capacity, but because it is easy to conceptualize and put in place, and because many hospitalists came from residency programs in which the system was standard.
The gaps between theoretical and realized benefits become evident once a practice implements a jeopardy system. For example, it might be really busy today, but Dr. Stravinsky doesn’t call in Dr. Copeland, who is on jeopardy, because next week their roles will be reversed and Dr. Stravinsky sure hopes he won’t be called in. No one wants to be the weak doctor who calls in the jeopardy doctor and spoils what was otherwise a day off.
I’ve worked with a lot of practices who say they have a jeopardy system in place, but when I ask for the last time the jeopardy doctor was called in, they say it has been more than a year, or in some cases never. So even if the policy manual says they have a jeopardy system, the doctors never activate it, so it provides no benefit.
Practices that do utilize the jeopardy doctor have their own problems, such as assigning that doctor’s admissions the next day. The jeopardy doctor might provide some relief today, but they essentially just delay the work of having to get to know all of those new patients until the morning, when everyone is very busy with rounds. So while there might be significant benefit in activating the jeopardy system today, it could just delay the problem of high workload until the next morning, which isn’t much of a net benefit for the practice.
A small number of practices call in the jeopardy doctor frequently, and sometimes have that doctor continue to round on admitted patients for the next few days. This usage might get the most value out of the system, but the practice should consider if it is more cost-effective, and less stressful for the doctors, if the system were reversed. For example, instead of having the doctor on jeopardy and called in as necessary, the doctor would report to work and be given the day off or let go early when it isn’t busy.
Despite my reservations, if you are convinced the jeopardy system is valuable and cost-effective, keep it in place. However, if your group is thinking about options to handle surge capacity, don’t be too quick to adopt a jeopardy system. It usually falls far short of a perfect solution.
Patient Volume Cap
Another way to address the problem of unpredictable increases in patient volume is to establish a patient volume (e.g., total census) cap for the whole hospitalist practice. Like the jeopardy system, this is an appealingly uncomplicated idea, and hospitalists who have finished residency within the last few years all worked with a cap.
Except for the rarest of exceptions, this is a poor idea and should be avoided if at all possible. I’ll leave for another time a discussion of all the political and financial costs of a cap system, but trust me on this one. It is best to avoid a cap.
Stay Tuned …
Next month, I’ll examine other strategies to provide surge capacity. I think they’re more valuable than the two I’ve mentioned here, but I need to warn you that they aren’t perfect and are more complicated to operationalize. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelson flores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.
Unpredictable workloads and frequent interruptions are the things I regard as the most stressful components of work as a hospitalist. Your list might be very different, but I bet unpredictable workloads ranks at least in the top five of every hospitalist’s list.
I’ve discussed interruptions previously (see “Really, It’s Switch-Tasking,” p. 68, November 2008; “Technological Advance or Workplace Setback?” p. 69, December 2008), but this month and next will turn to unpredictable workloads. In other words, what are the strategies available to a hospitalist practice to provide surge capacity in response to such unpredictable increases in patient volume as an uptick in census or daily admissions 50% to 100% above normal? I’ll leave to others the topic of how hospitals respond to such disasters as terrorist attacks, earthquakes, etc.
The Bottom Line
Sadly, there is no magic bullet for the “surge” problem, and no way to protect on-duty hospitalists from the need to work harder when it gets busy. But we needn’t feel too sorry for ourselves; doctors in most other specialties who practice in the hospital face the same problem and tend to rely heavily on simply working harder and longer when it is unusually busy. Sometimes they couple the “work harder” mantra with other strategies, such as calling another doctor in to help.
Hospitalists have a duty to ensure high patient volume doesn’t lead to deterioration in the quality of patient care, but occasionally working longer days than average probably poses a low risk, and might be less risky than the additional handoffs usually associated with having a doctor on “jeopardy” to be called in when it’s busy. Routinely or frequently working unreasonably long days is another story.
The trick for HM programs is to build some surge capacity into the routine daily staffing 1) without exceeding a reasonable budget, while 2) ensuring that the hospitalists don’t simply become accustomed to light workloads as the only reasonable norm, which could lead to them becoming unwilling to accept higher, but still reasonable, workloads when needed. (More on these issues later.) First, I’ll go through what I see as the pros and cons of several approaches to addressing surges in patient volume. All are in use with variable frequency around the country.
“Jeopardy” System
In its most common form, a jeopardy system has an unscheduled doctor each day who must remain available on short notice by pager. When patient volume surges, the unscheduled doctor is paged to come in and help. In most cases, this doctor focuses primarily—or exclusively—on admitting patients for a few hours. So it is most common for this doctor to be called in late in the afternoon or early in the evening. The jeopardy doctor usually turns over all admitted patients to another hospitalist in the group for all subsequent care. In addition to providing surge capacity, the jeopardy doctor almost always is used to cover unexpected absences of scheduled doctors, including illness-related absences.
Sometimes this doctor is paid extra for each day or week spent being “available” on jeopardy duty (not to be confused with jury duty, though it can be equally difficult to get exempted from). Then again, it is not uncommon to have jeopardy duty included in base compensation. However, once a jeopardy doctor is actually called in to work, most practices pay additional compensation, often based on an hourly rate that usually is higher than the average compensation generated per hour for nonjeopardy work.
There are a number of reasonable ways to compensate the jeopardy doctor. You probably can get some good ideas by talking with others in your hospital who function in a similar capacity, such as cath-lab technicians who get called in on nights and weekends.
No definitive data are available to show how common the jeopardy system is, but my experience is that 30% to 50% of HM groups use some form of it. Its popularity is proof that it is a reasonable system, but I’m not convinced. I think it is in use by a lot of groups not because it is an optimal way to ensure surge capacity, but because it is easy to conceptualize and put in place, and because many hospitalists came from residency programs in which the system was standard.
The gaps between theoretical and realized benefits become evident once a practice implements a jeopardy system. For example, it might be really busy today, but Dr. Stravinsky doesn’t call in Dr. Copeland, who is on jeopardy, because next week their roles will be reversed and Dr. Stravinsky sure hopes he won’t be called in. No one wants to be the weak doctor who calls in the jeopardy doctor and spoils what was otherwise a day off.
I’ve worked with a lot of practices who say they have a jeopardy system in place, but when I ask for the last time the jeopardy doctor was called in, they say it has been more than a year, or in some cases never. So even if the policy manual says they have a jeopardy system, the doctors never activate it, so it provides no benefit.
Practices that do utilize the jeopardy doctor have their own problems, such as assigning that doctor’s admissions the next day. The jeopardy doctor might provide some relief today, but they essentially just delay the work of having to get to know all of those new patients until the morning, when everyone is very busy with rounds. So while there might be significant benefit in activating the jeopardy system today, it could just delay the problem of high workload until the next morning, which isn’t much of a net benefit for the practice.
A small number of practices call in the jeopardy doctor frequently, and sometimes have that doctor continue to round on admitted patients for the next few days. This usage might get the most value out of the system, but the practice should consider if it is more cost-effective, and less stressful for the doctors, if the system were reversed. For example, instead of having the doctor on jeopardy and called in as necessary, the doctor would report to work and be given the day off or let go early when it isn’t busy.
Despite my reservations, if you are convinced the jeopardy system is valuable and cost-effective, keep it in place. However, if your group is thinking about options to handle surge capacity, don’t be too quick to adopt a jeopardy system. It usually falls far short of a perfect solution.
Patient Volume Cap
Another way to address the problem of unpredictable increases in patient volume is to establish a patient volume (e.g., total census) cap for the whole hospitalist practice. Like the jeopardy system, this is an appealingly uncomplicated idea, and hospitalists who have finished residency within the last few years all worked with a cap.
Except for the rarest of exceptions, this is a poor idea and should be avoided if at all possible. I’ll leave for another time a discussion of all the political and financial costs of a cap system, but trust me on this one. It is best to avoid a cap.
Stay Tuned …
Next month, I’ll examine other strategies to provide surge capacity. I think they’re more valuable than the two I’ve mentioned here, but I need to warn you that they aren’t perfect and are more complicated to operationalize. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelson flores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.
Unpredictable workloads and frequent interruptions are the things I regard as the most stressful components of work as a hospitalist. Your list might be very different, but I bet unpredictable workloads ranks at least in the top five of every hospitalist’s list.
I’ve discussed interruptions previously (see “Really, It’s Switch-Tasking,” p. 68, November 2008; “Technological Advance or Workplace Setback?” p. 69, December 2008), but this month and next will turn to unpredictable workloads. In other words, what are the strategies available to a hospitalist practice to provide surge capacity in response to such unpredictable increases in patient volume as an uptick in census or daily admissions 50% to 100% above normal? I’ll leave to others the topic of how hospitals respond to such disasters as terrorist attacks, earthquakes, etc.
The Bottom Line
Sadly, there is no magic bullet for the “surge” problem, and no way to protect on-duty hospitalists from the need to work harder when it gets busy. But we needn’t feel too sorry for ourselves; doctors in most other specialties who practice in the hospital face the same problem and tend to rely heavily on simply working harder and longer when it is unusually busy. Sometimes they couple the “work harder” mantra with other strategies, such as calling another doctor in to help.
Hospitalists have a duty to ensure high patient volume doesn’t lead to deterioration in the quality of patient care, but occasionally working longer days than average probably poses a low risk, and might be less risky than the additional handoffs usually associated with having a doctor on “jeopardy” to be called in when it’s busy. Routinely or frequently working unreasonably long days is another story.
The trick for HM programs is to build some surge capacity into the routine daily staffing 1) without exceeding a reasonable budget, while 2) ensuring that the hospitalists don’t simply become accustomed to light workloads as the only reasonable norm, which could lead to them becoming unwilling to accept higher, but still reasonable, workloads when needed. (More on these issues later.) First, I’ll go through what I see as the pros and cons of several approaches to addressing surges in patient volume. All are in use with variable frequency around the country.
“Jeopardy” System
In its most common form, a jeopardy system has an unscheduled doctor each day who must remain available on short notice by pager. When patient volume surges, the unscheduled doctor is paged to come in and help. In most cases, this doctor focuses primarily—or exclusively—on admitting patients for a few hours. So it is most common for this doctor to be called in late in the afternoon or early in the evening. The jeopardy doctor usually turns over all admitted patients to another hospitalist in the group for all subsequent care. In addition to providing surge capacity, the jeopardy doctor almost always is used to cover unexpected absences of scheduled doctors, including illness-related absences.
Sometimes this doctor is paid extra for each day or week spent being “available” on jeopardy duty (not to be confused with jury duty, though it can be equally difficult to get exempted from). Then again, it is not uncommon to have jeopardy duty included in base compensation. However, once a jeopardy doctor is actually called in to work, most practices pay additional compensation, often based on an hourly rate that usually is higher than the average compensation generated per hour for nonjeopardy work.
There are a number of reasonable ways to compensate the jeopardy doctor. You probably can get some good ideas by talking with others in your hospital who function in a similar capacity, such as cath-lab technicians who get called in on nights and weekends.
No definitive data are available to show how common the jeopardy system is, but my experience is that 30% to 50% of HM groups use some form of it. Its popularity is proof that it is a reasonable system, but I’m not convinced. I think it is in use by a lot of groups not because it is an optimal way to ensure surge capacity, but because it is easy to conceptualize and put in place, and because many hospitalists came from residency programs in which the system was standard.
The gaps between theoretical and realized benefits become evident once a practice implements a jeopardy system. For example, it might be really busy today, but Dr. Stravinsky doesn’t call in Dr. Copeland, who is on jeopardy, because next week their roles will be reversed and Dr. Stravinsky sure hopes he won’t be called in. No one wants to be the weak doctor who calls in the jeopardy doctor and spoils what was otherwise a day off.
I’ve worked with a lot of practices who say they have a jeopardy system in place, but when I ask for the last time the jeopardy doctor was called in, they say it has been more than a year, or in some cases never. So even if the policy manual says they have a jeopardy system, the doctors never activate it, so it provides no benefit.
Practices that do utilize the jeopardy doctor have their own problems, such as assigning that doctor’s admissions the next day. The jeopardy doctor might provide some relief today, but they essentially just delay the work of having to get to know all of those new patients until the morning, when everyone is very busy with rounds. So while there might be significant benefit in activating the jeopardy system today, it could just delay the problem of high workload until the next morning, which isn’t much of a net benefit for the practice.
A small number of practices call in the jeopardy doctor frequently, and sometimes have that doctor continue to round on admitted patients for the next few days. This usage might get the most value out of the system, but the practice should consider if it is more cost-effective, and less stressful for the doctors, if the system were reversed. For example, instead of having the doctor on jeopardy and called in as necessary, the doctor would report to work and be given the day off or let go early when it isn’t busy.
Despite my reservations, if you are convinced the jeopardy system is valuable and cost-effective, keep it in place. However, if your group is thinking about options to handle surge capacity, don’t be too quick to adopt a jeopardy system. It usually falls far short of a perfect solution.
Patient Volume Cap
Another way to address the problem of unpredictable increases in patient volume is to establish a patient volume (e.g., total census) cap for the whole hospitalist practice. Like the jeopardy system, this is an appealingly uncomplicated idea, and hospitalists who have finished residency within the last few years all worked with a cap.
Except for the rarest of exceptions, this is a poor idea and should be avoided if at all possible. I’ll leave for another time a discussion of all the political and financial costs of a cap system, but trust me on this one. It is best to avoid a cap.
Stay Tuned …
Next month, I’ll examine other strategies to provide surge capacity. I think they’re more valuable than the two I’ve mentioned here, but I need to warn you that they aren’t perfect and are more complicated to operationalize. TH
Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelson flores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.